{"meta":{"query_hash":"db851563d35d","filters":{"venue":"Bladder Cancer"},"cohort_total":54,"direct_labels_cover":0,"predictions_cover":54,"exported":54,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/db851563d35d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Bladder+Cancer"},"results":[{"id":"W1621391416","doi":"10.3233/blc-150018","title":"The Role of Population-Based Observational Research in Bladder Cancer","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Observational study; Bladder cancer; Psychological intervention; Population; Clinical trial; Clinical Practice; Cancer; Medicine; Translational research; Family medicine; Nursing; Environmental health; Pathology; Internal medicine","score_opus":0.2850106155848942,"score_gpt":0.491273960381424,"score_spread":0.2062633447965298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1621391416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015306652,0.9839295,0.0049051237,0.0061254436,0.0014419174,0.00022052732,0.0007753975,0.000021486514,0.0010500086],"genre_scores_gemma":[0.0461857,0.93037003,0.011323011,0.007856381,0.0018534199,0.0011219198,0.0009139141,0.00003671634,0.00033892633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.87958324,0.093080394,0.012215179,0.005085369,0.009418527,0.000617314],"domain_scores_gemma":[0.49138498,0.463283,0.017837815,0.01710186,0.009646873,0.00074550736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13836761,0.0010283926,0.0060513266,0.0038316883,0.0007339708,0.0041522076,0.0028215956,0.0035830305,0.0037242624],"category_scores_gemma":[0.29134437,0.0010636131,0.004631061,0.006597506,0.0026510023,0.0051495684,0.0029619345,0.0044572577,0.00042687045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072592654,0.00017310065,0.03098377,0.2678292,0.024412367,0.00017786966,0.0013991225,0.0022232237,0.00032986107,0.030154202,0.017610064,0.62398136],"study_design_scores_gemma":[0.0007987033,0.00095918187,0.0968647,0.44039932,0.033864897,0.0013418717,0.0016951198,0.0030131221,0.0009751847,0.073506445,0.34626403,0.00031744645],"about_ca_topic_score_codex":0.007408924,"about_ca_topic_score_gemma":0.006891018,"teacher_disagreement_score":0.13836761,"about_ca_system_score_codex":0.0024107527,"about_ca_system_score_gemma":0.010658945,"threshold_uncertainty_score":0.7317666},"labels":[],"label_agreement":null},{"id":"W1831939955","doi":"10.1002/9781118674826.ch3","title":"Utility of urine biomarkers","year":2015,"lang":"en","type":"other","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Cystoscopy; Bladder cancer; Urine cytology; Medicine; Urine; Cytology; Urinary system; Urology; Cancer; Urinary bladder; Internal medicine; Pathology","score_opus":0.035585582907429025,"score_gpt":0.32316588186901146,"score_spread":0.28758029896158244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1831939955","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016529856,0.87844086,0.026414566,0.007910609,0.0031213376,0.00032187568,0.002977802,0.0008026478,0.063480385],"genre_scores_gemma":[0.21260606,0.6802007,0.056112595,0.006637193,0.003733606,0.00050734705,0.0049848966,0.00037012968,0.034847427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668926,0.00088609237,0.0003231956,0.00046088675,0.0014351932,0.00020545306],"domain_scores_gemma":[0.9977362,0.0008802475,0.00035313593,0.00014478246,0.0007716343,0.000113896356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036787707,0.0010350553,0.0012282751,0.0041538803,0.0006107905,0.003837832,0.0010128707,0.0014773929,0.0067857592],"category_scores_gemma":[0.006319842,0.00036818895,0.0015418122,0.0026241043,0.0007367472,0.0017083334,0.0015221512,0.0012215665,0.0032573023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035285534,0.00014240948,0.020904372,0.0052770074,0.0003603926,0.00083185005,0.00028850368,0.0009248218,0.006292502,0.010940294,0.024521085,0.929164],"study_design_scores_gemma":[0.00004532193,0.00058414205,0.02227482,0.0060051484,0.00080664316,0.0093973195,0.00037724,0.001411397,0.027069036,0.011414227,0.92046076,0.000153931],"about_ca_topic_score_codex":0.0021060389,"about_ca_topic_score_gemma":0.00197122,"teacher_disagreement_score":0.0067857592,"about_ca_system_score_codex":0.0012857327,"about_ca_system_score_gemma":0.001901835,"threshold_uncertainty_score":0.022700608},"labels":[],"label_agreement":null},{"id":"W2191471066","doi":"10.3233/blc-150021","title":"Bladder Cancer Patient Advocacy: A Global Perspective","year":2015,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bladder cancer; Globe; Patient advocacy; Medicine; Public relations; Political science; Non profit; Perspective (graphical); Cancer; Nursing; Family medicine; MEDLINE; Public administration; Internal medicine","score_opus":0.07879779033624489,"score_gpt":0.4203128336327744,"score_spread":0.3415150432965295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191471066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031217813,0.9466574,0.00018268851,0.046368405,0.0014700716,0.000010058847,0.000016592017,0.000008438469,0.0049741105],"genre_scores_gemma":[0.0066129705,0.9732641,0.00029494194,0.017084042,0.0017291805,0.000026774816,0.00002671735,0.000005867254,0.00095534587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727124,0.0016324086,0.00026059084,0.00015482758,0.00047088997,0.00020997894],"domain_scores_gemma":[0.9931948,0.0047122044,0.00048962753,0.00008271382,0.0008415748,0.0006791261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055843564,0.0006683605,0.0011061413,0.0025809398,0.0012414213,0.0042135366,0.0010362304,0.0056407102,0.0059806705],"category_scores_gemma":[0.009237197,0.00029356196,0.00066268764,0.0034671072,0.0020483853,0.005339428,0.0031897225,0.005532984,0.0009790517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006167403,0.00011305337,0.00080908753,0.025246628,0.000145645,0.00062297116,0.0045572566,0.00022622546,0.0002586205,0.04821849,0.17566188,0.7440785],"study_design_scores_gemma":[0.000013742199,0.00003602732,0.0005499748,0.021121703,0.000052089246,0.0012323142,0.001880236,0.000034355646,0.00004880999,0.006579036,0.96843743,0.000014225991],"about_ca_topic_score_codex":0.0012294175,"about_ca_topic_score_gemma":0.0023203748,"teacher_disagreement_score":0.0059806705,"about_ca_system_score_codex":0.0018379565,"about_ca_system_score_gemma":0.00566433,"threshold_uncertainty_score":0.029533267},"labels":[],"label_agreement":null},{"id":"W2257398199","doi":"10.3233/blc-150033","title":"Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cystectomy; Bladder cancer; Medicine; Proportional hazards model; Oncology; Internal medicine; Univariate analysis; GLUT1; Hypoxia (environmental); Cohort; Glucose transporter; Cancer; Multivariate analysis; Pathology","score_opus":0.01382848012899163,"score_gpt":0.2512026517575058,"score_spread":0.23737417162851415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257398199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989085,0.0007025005,0.000059513215,0.000057679878,0.000005858465,0.000002906552,0.00012974508,0.0000029465377,0.00013041348],"genre_scores_gemma":[0.99954396,0.00014567192,0.000033053184,0.00000918591,0.000009349041,0.0000024673418,0.00020090325,8.539266e-7,0.000054560383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988496,0.000023516797,0.0000084643425,0.00002801096,0.000025474954,0.000029493382],"domain_scores_gemma":[0.9993445,0.00015423996,0.00024593002,0.000033451117,0.00007034189,0.00015158737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002926348,0.00016463852,0.00027488888,0.0002919462,0.00032830873,0.00036259127,0.00023960345,0.0003190676,0.0011002288],"category_scores_gemma":[0.001233217,0.00010893908,0.00021419245,0.0004986226,0.00029317068,0.00018648627,0.00022032215,0.00028241266,0.00012637694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022750808,0.000009847765,0.9976719,0.000011979306,0.000026220367,0.00006842859,0.000027347522,0.00005028487,0.00050306576,0.0000042919373,0.00010397916,0.0012952145],"study_design_scores_gemma":[0.0000046440855,0.00005061328,0.9993278,0.0000039930655,0.000033848897,0.00020681584,0.000040267732,0.00011354132,0.00010485015,0.000008560627,0.00010323425,0.000001890026],"about_ca_topic_score_codex":0.0056657344,"about_ca_topic_score_gemma":0.0072888676,"teacher_disagreement_score":0.0056657344,"about_ca_system_score_codex":0.0004945655,"about_ca_system_score_gemma":0.0005807326,"threshold_uncertainty_score":0.011265457},"labels":[],"label_agreement":null},{"id":"W2258126254","doi":"10.3233/blc-150034","title":"Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Guideline; Nice; Medicine; Presentation (obstetrics); Bladder cancer; Family medicine; Cancer; Intensive care medicine; Pathology; Internal medicine; Computer science; Surgery","score_opus":0.16288173485036742,"score_gpt":0.47426121375546115,"score_spread":0.31137947890509377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258126254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015593459,0.98003536,0.0008336768,0.0064472104,0.00113882,0.0010217954,0.0017191478,0.000039103783,0.0072054304],"genre_scores_gemma":[0.023277763,0.952102,0.01201696,0.0053827013,0.00036635625,0.0023119156,0.0037676115,0.00003902372,0.0007356659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96894306,0.011994541,0.009936989,0.0008783192,0.007670428,0.00057666656],"domain_scores_gemma":[0.95317674,0.021564988,0.008871332,0.0008568234,0.014779556,0.0007506264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02558884,0.00097337546,0.0034413582,0.012152286,0.00071221654,0.002466868,0.0031810983,0.003001689,0.0035453865],"category_scores_gemma":[0.11193701,0.00066570006,0.004629081,0.014183155,0.0006986341,0.0026636273,0.0015644147,0.002168634,0.00066431495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056878605,0.00006820315,0.0038558196,0.37718293,0.004852657,0.0002628464,0.0010056272,0.00080370344,0.00033799556,0.0069728913,0.11307655,0.49101195],"study_design_scores_gemma":[0.0007134301,0.00029149224,0.014478946,0.57250035,0.013677912,0.00095779885,0.0008654481,0.00042566258,0.0004131061,0.0028411613,0.39272642,0.00010831485],"about_ca_topic_score_codex":0.016971447,"about_ca_topic_score_gemma":0.029621387,"teacher_disagreement_score":0.02558884,"about_ca_system_score_codex":0.0063946377,"about_ca_system_score_gemma":0.019707453,"threshold_uncertainty_score":0.13532835},"labels":[],"label_agreement":null},{"id":"W2263980547","doi":"10.3233/blc-150026","title":"Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer","year":2016,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Blockade; Immune checkpoint; Immune system; Medicine; Cancer; Immunotherapy; Oncology; Cancer research; Immunology; Internal medicine; Receptor","score_opus":0.08522930557432609,"score_gpt":0.39982140468445465,"score_spread":0.31459209911012853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263980547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001787124,0.99477416,0.00046237317,0.0013631355,0.00027017124,0.000014145001,0.00003801664,0.000022960392,0.0012680261],"genre_scores_gemma":[0.03397552,0.96140903,0.001033398,0.0015143768,0.00065161864,0.00003603341,0.0001222598,0.000008979772,0.0012488505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998185,0.00004900687,0.000027926815,0.000023343986,0.00006144541,0.000019794486],"domain_scores_gemma":[0.99976104,0.0000817227,0.00008227008,0.000008269782,0.000049179667,0.000017519604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006159281,0.00030905675,0.00043257602,0.0013627348,0.00015047009,0.0005203449,0.00036444847,0.00049464096,0.0023153585],"category_scores_gemma":[0.00064723945,0.00009347658,0.00066650537,0.00063741935,0.00024496228,0.0004590868,0.0003578521,0.0010086487,0.0006281584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035099353,0.00014969312,0.00083522627,0.015804928,0.00024348928,0.00036104387,0.00007334967,0.0009463085,0.012582678,0.002928955,0.017992968,0.94773024],"study_design_scores_gemma":[0.00035809417,0.0020569856,0.0061727576,0.013843348,0.0009209956,0.004597268,0.00015038338,0.0012710819,0.013956734,0.006464607,0.95014566,0.00006207233],"about_ca_topic_score_codex":0.00031016188,"about_ca_topic_score_gemma":0.0010871859,"teacher_disagreement_score":0.0023153585,"about_ca_system_score_codex":0.00039553107,"about_ca_system_score_gemma":0.0005332934,"threshold_uncertainty_score":0.007745683},"labels":[],"label_agreement":null},{"id":"W2342783650","doi":"10.3233/blc-169007","title":"Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think Tank","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Bladder cancer; Multidisciplinary approach; Variety (cybernetics); Multidisciplinary team; Medicine; Medical education; Public relations; Cancer; Psychology; Engineering ethics; Political science; Engineering; Computer science; Nursing; Artificial intelligence; Internal medicine","score_opus":0.0353898670531876,"score_gpt":0.3639863883548209,"score_spread":0.3285965213016333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342783650","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005043465,0.007629064,0.0056977794,0.7420131,0.2299986,0.0016269826,0.00041318213,0.00033940643,0.0072385026],"genre_scores_gemma":[0.11254245,0.017175367,0.04280766,0.5802456,0.16021807,0.013000621,0.0021012335,0.001583373,0.07032556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9173854,0.04796007,0.003905895,0.0047072857,0.015888985,0.010152219],"domain_scores_gemma":[0.7828104,0.07629931,0.009568234,0.004030098,0.04919062,0.07810141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1280002,0.0028721127,0.0021047266,0.004086709,0.0264009,0.02248087,0.006680081,0.025205938,0.017722722],"category_scores_gemma":[0.14822593,0.0025294444,0.0047156313,0.0027434586,0.008973187,0.010806402,0.025120698,0.051414408,0.004993736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047369485,0.0004177138,0.0007367317,0.0016405887,0.00018103438,0.001224992,0.031477023,0.0003244641,0.001188739,0.0037912505,0.9164304,0.04211343],"study_design_scores_gemma":[0.00029765113,0.00024756594,0.0011242034,0.0021755628,0.00011030647,0.0002602925,0.044864886,0.0004415104,0.0007474483,0.012738853,0.9367038,0.00028789588],"about_ca_topic_score_codex":0.008608888,"about_ca_topic_score_gemma":0.02665275,"teacher_disagreement_score":0.1280002,"about_ca_system_score_codex":0.027108364,"about_ca_system_score_gemma":0.089587174,"threshold_uncertainty_score":0.6769378},"labels":[],"label_agreement":null},{"id":"W2343178457","doi":"10.3233/blc-150032","title":"Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"University of Toronto","keywords":"Medicine; Cystectomy; Bladder cancer; Lymph node; Dissection (medical); Urology; Chemotherapy; Randomized controlled trial; Internal medicine; Surgery; Gynecology; Cancer","score_opus":0.0074304128108973674,"score_gpt":0.2530944535279718,"score_spread":0.2456640407170744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343178457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980653,0.0015409476,0.000018991812,0.0001143793,0.000009630494,0.000007221208,0.00006336802,0.000001426161,0.00017885953],"genre_scores_gemma":[0.9994997,0.00025330528,0.000025260773,0.00004547586,0.000017813765,0.000003972056,0.000121951,5.5967945e-7,0.000031846055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996055,0.00017350973,0.00003314461,0.00005363897,0.000051206443,0.000083041064],"domain_scores_gemma":[0.99812275,0.000627098,0.0006184807,0.000055614684,0.00007553238,0.00050045963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076839916,0.00018564462,0.00045703008,0.00022137185,0.0003005811,0.0005132339,0.00026476188,0.00043229258,0.0010004891],"category_scores_gemma":[0.0027993107,0.00010048587,0.0006720892,0.00050197844,0.00032647996,0.00022582227,0.00028402358,0.0003772153,0.00004938665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012611986,0.00022365982,0.97351855,0.00010685891,0.0003827292,0.00012444818,0.00006701539,0.000398437,0.0005042656,0.000026255146,0.00026950316,0.011766369],"study_design_scores_gemma":[0.00031424567,0.0015730666,0.996872,0.000033950804,0.00031908447,0.00017061339,0.00007483261,0.00025765956,0.00011215766,0.000039939816,0.00022697212,0.0000054195334],"about_ca_topic_score_codex":0.007202171,"about_ca_topic_score_gemma":0.015175253,"teacher_disagreement_score":0.007202171,"about_ca_system_score_codex":0.0011426748,"about_ca_system_score_gemma":0.0013077554,"threshold_uncertainty_score":0.014320493},"labels":[],"label_agreement":null},{"id":"W2532785857","doi":"10.3233/blc-160071","title":"Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Cystectomy; Medicine; Bladder cancer; Urology; Renal function; Stage (stratigraphy); Chemotherapy; Cohort; Logistic regression; Urothelial carcinoma; Internal medicine; Surgery; Oncology; Cancer","score_opus":0.011106744369064803,"score_gpt":0.30958864481717724,"score_spread":0.29848190044811246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532785857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958269,0.002937602,0.000059982453,0.0005203517,0.00001604085,0.000006349584,0.000098300734,0.000002371739,0.0005322027],"genre_scores_gemma":[0.9993642,0.00034849063,0.000053361306,0.000060993145,0.000028516442,0.0000018295334,0.00007621774,0.0000010029071,0.00006543198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903584,0.00039421237,0.0001046112,0.0001099971,0.00024191759,0.00011352861],"domain_scores_gemma":[0.993736,0.0023062332,0.0028936246,0.0001994905,0.00043004807,0.00043460785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013271631,0.000107337895,0.00029948584,0.00028912254,0.00021226188,0.0005232839,0.00025850232,0.00033848084,0.0011065534],"category_scores_gemma":[0.01111818,0.00009966975,0.00036601527,0.00052984274,0.00036837553,0.0004731597,0.00033064254,0.0004358447,0.00012268031],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025414495,0.000029825702,0.9929803,0.000016691783,0.000043457687,0.000050120434,0.000020396936,0.000051482763,0.00016678251,0.0000063703233,0.000056720273,0.006323837],"study_design_scores_gemma":[0.0000026357277,0.00015805736,0.9994342,0.000009688338,0.000022210244,0.00009133231,0.000044524764,0.00006741041,0.000055312546,0.0000051692423,0.000108033666,0.0000013891124],"about_ca_topic_score_codex":0.0037873748,"about_ca_topic_score_gemma":0.010406935,"teacher_disagreement_score":0.0037873748,"about_ca_system_score_codex":0.0005391357,"about_ca_system_score_gemma":0.0006692825,"threshold_uncertainty_score":0.0075306296},"labels":[],"label_agreement":null},{"id":"W2580444273","doi":"10.3233/blc-160081","title":"The Rationale for Post-Operative Radiation in Localized Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Radiation therapy; Medical physics; General surgery; Radiology; Internal medicine","score_opus":0.1166406513632305,"score_gpt":0.45455093499995636,"score_spread":0.33791028363672587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580444273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055910474,0.9974273,0.00007817763,0.0013132455,0.00034670095,0.000008055912,0.000019564512,0.0000032137914,0.00074781995],"genre_scores_gemma":[0.00093816745,0.9962936,0.00022724165,0.0017157051,0.0002604362,0.000019247575,0.00003394091,0.0000020204814,0.00050960964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994103,0.00020282388,0.0001315308,0.00008643417,0.00014403669,0.000024873914],"domain_scores_gemma":[0.99914455,0.0005525361,0.000113287766,0.000029909766,0.0001394129,0.00002038683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014578876,0.00069093413,0.0012104425,0.0017510902,0.00030628484,0.0011181954,0.0014678459,0.0020479828,0.004503356],"category_scores_gemma":[0.0022855622,0.00028351689,0.0012406063,0.0018936483,0.0011527302,0.0019164591,0.0006312783,0.003167472,0.0015634497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013259717,0.000076051765,0.00025892825,0.06752586,0.0002820685,0.00022359041,0.00014367848,0.00038681508,0.0006225658,0.01783661,0.057239074,0.8552722],"study_design_scores_gemma":[0.000058022863,0.00008128062,0.001005971,0.03507591,0.00031401013,0.0014168293,0.00008547145,0.000064114996,0.00023998761,0.0053360574,0.95630074,0.000021582186],"about_ca_topic_score_codex":0.0015845748,"about_ca_topic_score_gemma":0.002377471,"teacher_disagreement_score":0.004503356,"about_ca_system_score_codex":0.0009540907,"about_ca_system_score_gemma":0.0018954418,"threshold_uncertainty_score":0.015065253},"labels":[],"label_agreement":null},{"id":"W2581289368","doi":"10.3233/blc-160084","title":"Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive Patients","year":2016,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Campbell Scientific (Canada)","funders":"","keywords":"Medicine; Cystoscopy; Biopsy; Cytology; Internal medicine; BCG vaccine; Urology; Surgery; Urinary system; Vaccination; Pathology","score_opus":0.023480088925008715,"score_gpt":0.2858945950353526,"score_spread":0.2624145061103439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581289368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855655,0.0011242375,0.000071063354,0.000028040895,0.0000033756344,0.000013258232,0.00003862738,0.000003308466,0.00016160845],"genre_scores_gemma":[0.99968195,0.00011864995,0.000057726742,0.00002245545,0.00001026005,0.000006793888,0.000079120175,7.3476014e-7,0.000022380322],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961203,0.000187362,0.000042432115,0.000056998873,0.000055228713,0.000046059187],"domain_scores_gemma":[0.9987851,0.00051691954,0.0003614378,0.0000897817,0.00005771511,0.00018895745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014563681,0.00015049247,0.00032985292,0.0003465171,0.00016257372,0.00031417908,0.00027032447,0.00024667062,0.00040406256],"category_scores_gemma":[0.002096599,0.00006511367,0.00022551586,0.00022128005,0.00027127823,0.00026716958,0.00022180285,0.00027580533,0.00007825858],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016496956,0.0011233034,0.9111937,0.00018659036,0.00024067315,0.0003793124,0.00024241349,0.00069036166,0.012512559,0.00007108324,0.00020797322,0.056654956],"study_design_scores_gemma":[0.00086595945,0.034465346,0.9524675,0.000052351217,0.00032987303,0.0015785446,0.00016401004,0.0014571706,0.0073988005,0.00009264934,0.0011137633,0.000014152087],"about_ca_topic_score_codex":0.0002211497,"about_ca_topic_score_gemma":0.00028246545,"teacher_disagreement_score":0.0014563681,"about_ca_system_score_codex":0.0002735547,"about_ca_system_score_gemma":0.00019039771,"threshold_uncertainty_score":0.007702112},"labels":[],"label_agreement":null},{"id":"W2606278562","doi":"10.3233/blc-160090","title":"Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Everolimus; Medicine; Clinical endpoint; Bladder cancer; Toxicity; Radiation therapy; Gemcitabine; Internal medicine; Urology; Oncology; Cohort; Clinical trial; Biopsy; Surgery; Cancer","score_opus":0.06506383417355531,"score_gpt":0.391303302315246,"score_spread":0.3262394681416907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606278562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945708,0.0013536838,0.0002942715,0.00035450113,0.000091363065,0.0020241041,0.00036971286,0.00004057395,0.00090093893],"genre_scores_gemma":[0.9908948,0.0011538042,0.0012241371,0.00066921086,0.00014954944,0.0029558635,0.001203257,0.000015402295,0.0017339272],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996793,0.00014970211,0.000017807335,0.00004832427,0.0000249216,0.00007999897],"domain_scores_gemma":[0.9993463,0.000081616075,0.00013335834,0.00004684502,0.000035666988,0.00035622573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001471715,0.0012685263,0.001781121,0.00036684054,0.00039653268,0.0008305973,0.00080076396,0.001075409,0.003621455],"category_scores_gemma":[0.00069616735,0.0005041538,0.00091180013,0.00039563875,0.00077891315,0.0005651092,0.0004165191,0.0031938353,0.0006710383],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74206096,0.102695666,0.008680187,0.0011857289,0.0014448317,0.00035484115,0.00042166325,0.002917092,0.06602322,0.00028113337,0.0032407187,0.07069395],"study_design_scores_gemma":[0.41909596,0.5658174,0.0078194905,0.00004116428,0.0003370316,0.00021834942,0.000042103908,0.00072939415,0.0041202637,0.000099232646,0.0016618706,0.000017770575],"about_ca_topic_score_codex":0.00057105464,"about_ca_topic_score_gemma":0.0015984777,"teacher_disagreement_score":0.003621455,"about_ca_system_score_codex":0.00070057926,"about_ca_system_score_gemma":0.001612061,"threshold_uncertainty_score":0.012115002},"labels":[],"label_agreement":null},{"id":"W2606921055","doi":"10.3233/blc-160086","title":"Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"European Association of Urology","keywords":"Medicine; Urology; Cystectomy; Stromal cell; Prostate; Lamina propria; Lymphovascular invasion; Carcinoma in situ; Carcinoma; Prostatic urethra; Internal medicine; Oncology; Cancer; Bladder cancer; Pathology; Metastasis; Epithelium","score_opus":0.0703343992348148,"score_gpt":0.3408266273139776,"score_spread":0.27049222807916284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606921055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993167,0.0003835403,0.00004064454,0.00001905531,0.000002147776,0.0000013076035,0.000060264396,0.0000016233149,0.0001747824],"genre_scores_gemma":[0.999861,0.000039552033,0.0000114945005,0.0000028736004,0.0000037376126,5.8351014e-7,0.000052246385,4.0737825e-7,0.000028112463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968374,0.000098996854,0.000026202,0.00005828456,0.00006897984,0.00006381837],"domain_scores_gemma":[0.9983412,0.0006022917,0.0005738523,0.000078716155,0.00011320963,0.0002907637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053467683,0.00012897428,0.00019361262,0.0003230137,0.00018371818,0.00038275978,0.00014438496,0.000155124,0.0012289241],"category_scores_gemma":[0.001869905,0.000081702055,0.00031631294,0.00031246268,0.00025465776,0.00026144844,0.00034510627,0.00025047746,0.00009708485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016138557,0.000012430354,0.9972554,0.0000069796824,0.00005859939,0.000071033384,0.000020811804,0.00006977264,0.00022259742,0.0000042584884,0.000022785107,0.002093934],"study_design_scores_gemma":[0.000001963016,0.00009015715,0.99932027,0.0000029472155,0.000025753836,0.0003128415,0.000029503188,0.00008727512,0.00007481722,0.0000052637947,0.00004782656,0.0000013383925],"about_ca_topic_score_codex":0.00093470066,"about_ca_topic_score_gemma":0.001724661,"teacher_disagreement_score":0.0012289241,"about_ca_system_score_codex":0.00018502928,"about_ca_system_score_gemma":0.00019909616,"threshold_uncertainty_score":0.004111171},"labels":[],"label_agreement":null},{"id":"W2609244474","doi":"10.3233/blc-170105","title":"CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer","year":2017,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Bladder cancer; Cancer; Oncology; Disease; Internal medicine; Targeted therapy; Chemotherapy; Cisplatin; Blockade","score_opus":0.31958293087640177,"score_gpt":0.48469369882958757,"score_spread":0.1651107679531858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609244474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036863266,0.9792797,0.0022633178,0.0084188385,0.0007522943,0.00004747709,0.000111581656,0.00007716706,0.0053631696],"genre_scores_gemma":[0.025361812,0.96201754,0.0030203569,0.0034636143,0.0017528596,0.00004919984,0.000210655,0.000021383046,0.0041025174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983203,0.00003569242,0.000014893991,0.000028984545,0.000059814385,0.000028519917],"domain_scores_gemma":[0.9998802,0.000032684206,0.000027121283,0.000004106112,0.000026923904,0.000028863518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005640789,0.00054905325,0.0007690822,0.0008406935,0.00028597834,0.0009881115,0.0006085928,0.00082868454,0.0038300357],"category_scores_gemma":[0.00028300242,0.00016364841,0.0005079337,0.00046139027,0.00034888837,0.0014046243,0.0006402822,0.003205168,0.0011357762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043445182,0.00029502728,0.0006652303,0.004128099,0.0000847285,0.00049830455,0.00011319494,0.0006996137,0.0113408035,0.007295661,0.0323743,0.94207054],"study_design_scores_gemma":[0.00024359545,0.0023298026,0.0027782489,0.0025028347,0.00028872828,0.0039410098,0.00012733355,0.0014023017,0.0053798314,0.0075941654,0.97335523,0.00005692016],"about_ca_topic_score_codex":0.00044196963,"about_ca_topic_score_gemma":0.0026178963,"teacher_disagreement_score":0.0038300357,"about_ca_system_score_codex":0.00057057996,"about_ca_system_score_gemma":0.0007131623,"threshold_uncertainty_score":0.012812793},"labels":[],"label_agreement":null},{"id":"W2732881054","doi":"10.3233/blc-170118","title":"Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer","year":2017,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Internal medicine; Cancer","score_opus":0.32443124169326165,"score_gpt":0.5705046334976933,"score_spread":0.24607339180443166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732881054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013457844,0.0018503169,0.001212797,0.9786008,0.012416471,0.00019945619,0.000041048825,0.00014385705,0.004189526],"genre_scores_gemma":[0.009224181,0.00093746965,0.0036759272,0.9644323,0.01615201,0.00025157383,0.000034987555,0.00007529393,0.005216232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9536173,0.025545709,0.005814016,0.0018939727,0.009857036,0.0032719031],"domain_scores_gemma":[0.7941527,0.14912973,0.010712404,0.006900023,0.020161023,0.018944146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08247682,0.0007697245,0.0017215507,0.0006691464,0.0046768324,0.008108505,0.0029792902,0.063811384,0.0069082137],"category_scores_gemma":[0.18184492,0.0008763069,0.0020992386,0.0008546533,0.0063317083,0.007699599,0.003240225,0.03255996,0.005164406],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065595674,0.00023526326,0.0011372938,0.00026692377,0.000041248248,0.0010191923,0.00070929795,0.00012810953,0.0017049788,0.008770061,0.8984111,0.08692056],"study_design_scores_gemma":[0.00093235,0.0013682424,0.0030238016,0.00095140067,0.00006105323,0.0011108763,0.00060304924,0.00055307517,0.0009901242,0.008761384,0.9815093,0.00013535154],"about_ca_topic_score_codex":0.0015283478,"about_ca_topic_score_gemma":0.0036711066,"teacher_disagreement_score":0.08247682,"about_ca_system_score_codex":0.0032907187,"about_ca_system_score_gemma":0.010866946,"threshold_uncertainty_score":0.4361843},"labels":[],"label_agreement":null},{"id":"W2767198233","doi":"10.3233/blc-170120","title":"Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer","year":2017,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Germinal center; Bladder cancer; Pathology; Follicular dendritic cells; CD20; Immune system; Lymphatic system; Cystectomy; H&E stain; CD8; CD3; Cancer; Medicine; Immunohistochemistry; B cell; T cell; Antibody; Immunology; Internal medicine; Antigen-presenting cell","score_opus":0.021314949336668693,"score_gpt":0.3151798573109079,"score_spread":0.29386490797423925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767198233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818844,0.00092106394,0.00014431901,0.000028544104,0.0000042787683,0.000008749965,0.00010001521,0.000007927961,0.0005966303],"genre_scores_gemma":[0.9995715,0.000101715465,0.000082476,0.0000058671353,0.000005240416,0.000005602754,0.00008386106,0.0000014909583,0.00014230503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984777,0.000032844433,0.000019013687,0.00003394978,0.000030551142,0.000035836612],"domain_scores_gemma":[0.9987482,0.0002324556,0.0005446262,0.00006293284,0.0001554571,0.00025636458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035105337,0.00012677777,0.00015995905,0.00068455096,0.00027168822,0.00046950634,0.00024457814,0.0003153476,0.0026201508],"category_scores_gemma":[0.0011076697,0.00011487575,0.0001619051,0.0006305583,0.0002423821,0.00026354167,0.00039392107,0.0003819027,0.00025990058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029074287,0.000025225332,0.99166834,0.000036550453,0.00001793496,0.00017279123,0.00008077774,0.000058601454,0.003951805,0.000021801432,0.00008930126,0.0035861714],"study_design_scores_gemma":[0.0000026696225,0.00011255068,0.99783367,0.00000788478,0.000019470906,0.0009269329,0.000091970935,0.000108705164,0.0005565322,0.00003416889,0.00030335464,0.0000021],"about_ca_topic_score_codex":0.0007491091,"about_ca_topic_score_gemma":0.0012564744,"teacher_disagreement_score":0.0026201508,"about_ca_system_score_codex":0.00023365144,"about_ca_system_score_gemma":0.00020156073,"threshold_uncertainty_score":0.00876534},"labels":[],"label_agreement":null},{"id":"W2784972860","doi":"10.3233/blc-170148","title":"Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Referral; Bladder cancer; Chemotherapy; Specialty; Family medicine; Logistic regression; Oncology; Internal medicine; Cancer","score_opus":0.039327710959015244,"score_gpt":0.3484307314601679,"score_spread":0.3091030205011527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784972860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703836,0.0002852597,0.0000860109,0.0007333002,0.000005491712,0.00011523754,0.0007750895,0.000004224901,0.00095706264],"genre_scores_gemma":[0.9979247,0.00055152766,0.000314367,0.00040276884,0.00000566756,0.00007785375,0.00044875714,0.000002338096,0.00027188763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806064,0.00038485945,0.0001457133,0.0001264905,0.0007206493,0.00056156697],"domain_scores_gemma":[0.9924475,0.001712232,0.0020030173,0.000098456345,0.0022112543,0.0015275425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025041157,0.000121854166,0.0002402339,0.00071748154,0.0012692388,0.00068456266,0.00036897726,0.0004066735,0.0017716029],"category_scores_gemma":[0.0092521245,0.0002919089,0.000252526,0.0020583703,0.00054815755,0.00041653556,0.00065679115,0.0007010114,0.0001735789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005310226,0.00010135406,0.978522,0.00015576262,0.000018361208,0.00009723524,0.012042845,0.00004668135,0.00030665146,0.0000370263,0.0016733512,0.006945664],"study_design_scores_gemma":[0.000010056343,0.0001005607,0.9795003,0.00010019683,0.000008897768,0.000096473465,0.01796456,0.00015246535,0.0000631916,0.000013702057,0.0019810018,0.00000850892],"about_ca_topic_score_codex":0.6637726,"about_ca_topic_score_gemma":0.7132034,"teacher_disagreement_score":0.6637726,"about_ca_system_score_codex":0.007055629,"about_ca_system_score_gemma":0.013340296,"threshold_uncertainty_score":0.676415},"labels":[],"label_agreement":null},{"id":"W2785240241","doi":"10.3233/blc-170140","title":"Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Liquid biopsy; Bladder cancer; Circulating tumor DNA; DNA; Biopsy; Medicine; Pathology; Cancer research; Oncology; Cancer; Internal medicine; Chemistry; Biochemistry","score_opus":0.07686118986522397,"score_gpt":0.3952291138831574,"score_spread":0.31836792401793346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785240241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000887548,0.99896276,0.00007788769,0.00021883783,0.00009067665,0.0000028804257,0.00001402486,0.0000037797686,0.0005404238],"genre_scores_gemma":[0.0006207218,0.9988084,0.000105553125,0.00010717824,0.00009064138,0.0000036842189,0.00002284136,8.659938e-7,0.00024015387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982834,0.000036208334,0.00003446684,0.000030645388,0.000056750072,0.000013612095],"domain_scores_gemma":[0.99957794,0.0002134925,0.00006749692,0.000010291496,0.00010105766,0.000029801307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053289556,0.0006356709,0.001018189,0.0030751242,0.00025482706,0.0008497256,0.00071865413,0.0009067493,0.0032379709],"category_scores_gemma":[0.0009872011,0.00021696751,0.00050870655,0.0023334334,0.00044121026,0.0012494641,0.00061210815,0.0011319267,0.0014582638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005753604,0.000051624327,0.00036047358,0.02367481,0.00009341978,0.00027299294,0.000071237424,0.0002796209,0.0007833047,0.00206216,0.022192648,0.95010024],"study_design_scores_gemma":[0.0000117069085,0.000082345025,0.0016392272,0.010215691,0.000205226,0.0031270508,0.00009976185,0.000112971604,0.00046406404,0.0020556368,0.9819629,0.00002340847],"about_ca_topic_score_codex":0.001027917,"about_ca_topic_score_gemma":0.0019142904,"teacher_disagreement_score":0.0032379709,"about_ca_system_score_codex":0.00043305545,"about_ca_system_score_gemma":0.0009587722,"threshold_uncertainty_score":0.010832071},"labels":[],"label_agreement":null},{"id":"W2785248624","doi":"10.3233/blc-170147","title":"Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Overweight; Observational study; Internal medicine; Body mass index; Meta-analysis; Randomized controlled trial; Obesity; Cancer; Oncology; Confidence interval","score_opus":0.08219347439400798,"score_gpt":0.37341704542907805,"score_spread":0.2912235710350701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785248624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010333925,0.99832386,0.0000986388,0.00011393105,0.000052065567,0.00007283296,0.00019712366,0.0000056615872,0.00010241662],"genre_scores_gemma":[0.022464182,0.9759747,0.0004930022,0.00030310598,0.00010179722,0.00026667933,0.00027698625,0.0000049355067,0.000114569666],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965144,0.0013739252,0.001124638,0.00034229297,0.0004936027,0.00015117897],"domain_scores_gemma":[0.9880812,0.009089778,0.0016474159,0.00020747214,0.00082954275,0.00014450941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063521084,0.0021227065,0.011566552,0.0061639394,0.0006033864,0.0022034023,0.0016947405,0.0017678392,0.0040697027],"category_scores_gemma":[0.018781086,0.000979047,0.01609055,0.0074533056,0.00047705762,0.0012177292,0.0011016269,0.0012480904,0.00027211334],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007932852,0.00003898571,0.004450088,0.80790067,0.1541623,0.00017208405,0.000091960836,0.00035169517,0.00017963414,0.0001640585,0.0015625873,0.030132577],"study_design_scores_gemma":[0.0004436989,0.00027570027,0.009927354,0.1492785,0.8318361,0.00032888833,0.00009494032,0.00024198422,0.00016773865,0.00034334316,0.0070181377,0.0000436269],"about_ca_topic_score_codex":0.007319136,"about_ca_topic_score_gemma":0.0178095,"teacher_disagreement_score":0.011566552,"about_ca_system_score_codex":0.0019593467,"about_ca_system_score_gemma":0.004517819,"threshold_uncertainty_score":0.033593595},"labels":[],"label_agreement":null},{"id":"W2801404059","doi":"10.3233/blc-170146","title":"Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention","year":2018,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital","funders":"","keywords":"Medicine; Cystectomy; Bladder cancer; Malignancy; Incidence (geometry); Population; Venous thromboembolism; Chemotherapy; Cancer; Disease; Intensive care medicine; Surgery; Internal medicine; Thrombosis","score_opus":0.02795026218785261,"score_gpt":0.33076070518830103,"score_spread":0.3028104430004484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801404059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001504748,0.9994423,0.00002243795,0.00014367801,0.00003877008,0.0000031945533,0.000021857268,9.805168e-7,0.00017634733],"genre_scores_gemma":[0.0013030366,0.9984548,0.000052850217,0.00007247298,0.000047201727,0.0000039875313,0.000019384726,2.7055614e-7,0.000045978803],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99960357,0.000101293466,0.00011999268,0.000049889186,0.00010493371,0.00002030105],"domain_scores_gemma":[0.99891555,0.00069622,0.00022690986,0.00001414042,0.00012401164,0.000023215147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006040651,0.00043664392,0.0010009615,0.0025460422,0.00021062304,0.0008724133,0.0005246904,0.0006720812,0.0019263724],"category_scores_gemma":[0.0026634005,0.00020330462,0.0008796175,0.0025621476,0.000255973,0.000696619,0.00034929905,0.0007489431,0.00024759144],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013755768,0.000052500505,0.0036476597,0.19150169,0.0009822244,0.00033434792,0.0002749167,0.00037255214,0.00038532197,0.0023212729,0.017523408,0.78246653],"study_design_scores_gemma":[0.00006716968,0.0003081604,0.018466664,0.2522948,0.0049302117,0.009331847,0.0006270578,0.00028883124,0.00048709233,0.0033186798,0.7098155,0.00006399659],"about_ca_topic_score_codex":0.002436437,"about_ca_topic_score_gemma":0.0044136173,"teacher_disagreement_score":0.0025460422,"about_ca_system_score_codex":0.0004820585,"about_ca_system_score_gemma":0.0016167499,"threshold_uncertainty_score":0.006444335},"labels":[],"label_agreement":null},{"id":"W2802165589","doi":"10.3233/blc-189032","title":"New Horizons in Bladder Cancer Research: Report of the 15th Meeting of the International Bladder Cancer Network (IBCN) in Lisbon, Portugal, October 21–23, 2017","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; Cancer; Medicine; Internal medicine","score_opus":0.07536507639488435,"score_gpt":0.38340234043299337,"score_spread":0.30803726403810905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802165589","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072763674,0.12529446,0.0027908147,0.43872514,0.4026303,0.0009823813,0.0040770583,0.0002588346,0.017964663],"genre_scores_gemma":[0.07822189,0.15692799,0.009436598,0.14276169,0.39497513,0.0019993533,0.014941941,0.0007585014,0.19997695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933443,0.0013957225,0.00032333433,0.0006820383,0.002152752,0.002101854],"domain_scores_gemma":[0.9846597,0.0010787742,0.00090596837,0.00017911618,0.0028111627,0.010365332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019866228,0.0020820384,0.0013801274,0.001870895,0.0023590163,0.0061464314,0.0019187388,0.0070516015,0.010940397],"category_scores_gemma":[0.005816465,0.0005969785,0.0017381476,0.0011037104,0.0017948236,0.0028662442,0.0061552026,0.009176639,0.0042976514],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003700777,0.0001426442,0.0018555239,0.0009961048,0.000055393855,0.00046854652,0.00042874838,0.000304993,0.0015070778,0.0013072809,0.952907,0.039656587],"study_design_scores_gemma":[0.00006941692,0.00015253725,0.0043646554,0.00086010183,0.000043088137,0.00019592635,0.00073244283,0.00020154016,0.0006745289,0.0007345063,0.9919252,0.00004615084],"about_ca_topic_score_codex":0.00641402,"about_ca_topic_score_gemma":0.0128652435,"teacher_disagreement_score":0.019866228,"about_ca_system_score_codex":0.0058838627,"about_ca_system_score_gemma":0.02034555,"threshold_uncertainty_score":0.105063915},"labels":[],"label_agreement":null},{"id":"W2802549022","doi":"10.3233/blc-170133","title":"The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Neutrophil to lymphocyte ratio; Bladder cancer; Proportional hazards model; Confidence interval; Chemotherapy; Multivariate analysis; Retrospective cohort study; Cancer; Gastroenterology; Lymphocyte; Oncology","score_opus":0.010819790376582641,"score_gpt":0.26331263171826613,"score_spread":0.2524928413416835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802549022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991066,0.00042005946,0.000054809567,0.00001824735,0.0000028915035,0.000009536672,0.0001943279,0.000001712153,0.00019177071],"genre_scores_gemma":[0.99968994,0.000066007626,0.000037260677,0.0000111442805,0.0000037060076,0.0000060209363,0.00015925302,5.846205e-7,0.000026067599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.00023138076,0.00013634928,0.00014967899,0.00016691754,0.0001117854],"domain_scores_gemma":[0.99719703,0.00049522903,0.0014469533,0.00022567855,0.00032029295,0.00031490924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013645906,0.00018187951,0.00032959075,0.0005848121,0.00041113418,0.0006254358,0.000378687,0.0002749156,0.0005419305],"category_scores_gemma":[0.0026038254,0.00018607595,0.0003123757,0.0012316885,0.00035750805,0.00039198442,0.00045421656,0.00032848437,0.000107057815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078124154,0.0000061277065,0.9995055,0.0000039268625,0.000017585136,0.000022650893,0.000018575378,0.000013945538,0.000038955033,0.000002393519,0.00001562863,0.00027655717],"study_design_scores_gemma":[0.0000056618665,0.0001272329,0.9990465,0.0000058656647,0.000040323488,0.00030694623,0.00012931591,0.00011105687,0.000052144813,0.0000072062817,0.00016450594,0.0000032397172],"about_ca_topic_score_codex":0.0065489337,"about_ca_topic_score_gemma":0.009632124,"teacher_disagreement_score":0.0065489337,"about_ca_system_score_codex":0.00068124087,"about_ca_system_score_gemma":0.00065652706,"threshold_uncertainty_score":0.013021648},"labels":[],"label_agreement":null},{"id":"W2884031435","doi":"10.3233/blc-180175","title":"Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Agence Nationale de la Recherche; Bladder Cancer Canada","keywords":"Bladder cancer; Immunotherapy; Context (archaeology); Medicine; Cancer; Disease; Perspective (graphical); Clinical trial; Cancer immunotherapy; Tumor microenvironment; Immune system; Oncology; Immunology; Internal medicine; Biology; Computer science","score_opus":0.03307595279235583,"score_gpt":0.3637603148918905,"score_spread":0.33068436209953467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884031435","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003522003,0.5833603,0.0027484363,0.38415542,0.0132956365,0.00006002409,0.00006599988,0.000069835856,0.012722291],"genre_scores_gemma":[0.06622987,0.79160535,0.011349175,0.08297411,0.037639577,0.00019408975,0.00012180927,0.000048165955,0.009837762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843603,0.00089711865,0.00011757069,0.00007940389,0.00027235664,0.00019755762],"domain_scores_gemma":[0.997131,0.0015579471,0.00020767923,0.00010432495,0.0004394838,0.00055956026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009622108,0.00048398375,0.0007293813,0.0014063335,0.0009976375,0.0041457927,0.0006442515,0.0029504814,0.0053350893],"category_scores_gemma":[0.004548212,0.0002798676,0.0004949624,0.0006412917,0.0033424255,0.0040925764,0.0018754,0.006050263,0.00092300336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003322948,0.0004649567,0.002670103,0.0034844114,0.000054123633,0.00056388543,0.0009193978,0.00073957175,0.0074880146,0.11810696,0.24186166,0.6233147],"study_design_scores_gemma":[0.000081202,0.0006241058,0.0031952676,0.0026605427,0.000041697756,0.0008304362,0.0015513673,0.00040990324,0.0022368087,0.07492817,0.91338986,0.0000505947],"about_ca_topic_score_codex":0.0010877552,"about_ca_topic_score_gemma":0.0036659578,"teacher_disagreement_score":0.009622108,"about_ca_system_score_codex":0.002680686,"about_ca_system_score_gemma":0.0047576916,"threshold_uncertainty_score":0.050887227},"labels":[],"label_agreement":null},{"id":"W2896542733","doi":"10.3233/blc-180184","title":"Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Cancer Care Ontario","keywords":"Medicine; Cystectomy; Venous thromboembolism; Bladder cancer; Chemotherapy; Incidence (geometry); Perioperative; Cancer; Urology; Surgery; Internal medicine; Thrombosis","score_opus":0.0234294671760765,"score_gpt":0.3434250159803532,"score_spread":0.31999554880427666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896542733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833953,0.00043150783,0.000049893762,0.00008867667,0.0000044903104,0.00002101286,0.0005945034,0.0000021878745,0.0004681258],"genre_scores_gemma":[0.9993093,0.0002133529,0.000031543408,0.00003657097,0.000009272906,0.000008467517,0.00032246744,7.4090514e-7,0.00006821628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993414,0.00010587347,0.00006899194,0.00013513041,0.00021900285,0.00012961599],"domain_scores_gemma":[0.99837947,0.00014646254,0.0008787049,0.00009707107,0.00020519846,0.00029313317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046583297,0.00018501357,0.00025561862,0.00054422725,0.0004963741,0.0007301602,0.00053051056,0.00043909327,0.0010232315],"category_scores_gemma":[0.0021444194,0.00032029187,0.00043363895,0.0017197627,0.00034018944,0.00043788966,0.0004436564,0.00061273004,0.00012266253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020933598,0.00001537428,0.999521,0.000006369827,0.000025717647,0.000022152859,0.000037709236,0.000009121346,0.00002405218,0.000004769821,0.000053719927,0.00025919094],"study_design_scores_gemma":[0.0000038396124,0.00002392192,0.999681,0.0000047958597,0.000014818343,0.00006919582,0.00006896188,0.000037630987,0.0000042685047,0.000004001557,0.00008630141,0.000001266072],"about_ca_topic_score_codex":0.11633825,"about_ca_topic_score_gemma":0.15323709,"teacher_disagreement_score":0.11633825,"about_ca_system_score_codex":0.0014837063,"about_ca_system_score_gemma":0.0016655173,"threshold_uncertainty_score":0.23132217},"labels":[],"label_agreement":null},{"id":"W2898021123","doi":"10.3233/blc-189037","title":"A Festschrift in Honor of Edward M. Messing, MD, FACS","year":2018,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Honor; Medicine; Gerontology; Computer science","score_opus":0.024279809841021176,"score_gpt":0.33363532590499817,"score_spread":0.309355516063977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898021123","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016224785,0.013786985,0.0012863136,0.5283177,0.43283698,0.00014281222,0.0004155718,0.00015104287,0.021440148],"genre_scores_gemma":[0.029703246,0.02875131,0.0024360353,0.22805019,0.4224422,0.00035780724,0.00076381356,0.00047004086,0.28702533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976561,0.0005211795,0.0001704011,0.00043424295,0.0008599163,0.00035818826],"domain_scores_gemma":[0.9849569,0.0020380195,0.00067008997,0.00040708043,0.005339291,0.0065886844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035101653,0.00080809055,0.0011497774,0.00081347977,0.0018646688,0.0030511154,0.0011036153,0.0030582005,0.05977822],"category_scores_gemma":[0.025185315,0.0004481374,0.0007710588,0.00042499276,0.0010501917,0.0018517175,0.0020020402,0.0078001665,0.031847376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063230465,0.00002323835,0.00031286833,0.000053841548,0.000010227083,0.00036987272,0.000038660117,0.000037494265,0.00016013984,0.00046068206,0.98480994,0.01365988],"study_design_scores_gemma":[0.000049848604,0.00008584791,0.0009928562,0.00017663023,0.000013825333,0.00273859,0.00021211704,0.00016075712,0.00033122973,0.0010076064,0.9942022,0.00002842743],"about_ca_topic_score_codex":0.0027949493,"about_ca_topic_score_gemma":0.005464932,"teacher_disagreement_score":0.05977822,"about_ca_system_score_codex":0.0019082205,"about_ca_system_score_gemma":0.0040664263,"threshold_uncertainty_score":0.19997805},"labels":[],"label_agreement":null},{"id":"W2913908440","doi":"10.1016/b978-0-12-809939-1.00032-1","title":"Microbiome","year":2017,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science","score_opus":0.038567343996304626,"score_gpt":0.31177386915045674,"score_spread":0.2732065251541521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913908440","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016257999,0.032849915,0.0056865825,0.014069407,0.006815135,0.000043352054,0.0004160601,0.00024960426,0.9382442],"genre_scores_gemma":[0.011890524,0.029043624,0.0046596616,0.006876925,0.0018178279,0.00009120111,0.00038088614,0.00019388701,0.9450455],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997181,0.00007474357,0.0000066309403,0.000046052,0.00011675097,0.000037612288],"domain_scores_gemma":[0.99988866,0.000024235613,0.000009933659,0.00001595032,0.000031725685,0.000029543824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034961887,0.0005396422,0.00029320395,0.00067738077,0.00089678844,0.0026099314,0.0003642076,0.0010235524,0.05923948],"category_scores_gemma":[0.00084397703,0.00017004077,0.00020929996,0.0006022264,0.00095848256,0.002310793,0.0024127995,0.0016874614,0.025177581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027167524,0.000030293952,0.00023685282,0.0003582167,0.0000092989685,0.00013436766,0.0008725449,0.00014230164,0.003099003,0.21871096,0.4239473,0.3524318],"study_design_scores_gemma":[6.669151e-7,0.0000037953776,0.00008367424,0.00008766292,0.0000010062687,0.00005656291,0.000091833615,0.000011363823,0.00013635776,0.008955934,0.9905691,0.0000018531819],"about_ca_topic_score_codex":0.001008066,"about_ca_topic_score_gemma":0.002454731,"teacher_disagreement_score":0.05923948,"about_ca_system_score_codex":0.00082221127,"about_ca_system_score_gemma":0.0010901033,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2950270989","doi":"10.3233/blc-190218","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2019,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Oncology; Internal medicine; Bladder cancer; PD-L1; Meta-analysis; Immunotherapy; Blockade; Clinical trial; Disease; Cancer","score_opus":0.03949301475115467,"score_gpt":0.3752436445870284,"score_spread":0.3357506298358737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950270989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010571571,0.9983443,0.00004360935,0.000115629395,0.00004001647,0.00008193856,0.00015198589,0.0000022192723,0.00016317201],"genre_scores_gemma":[0.024929237,0.973125,0.0005188353,0.00051020976,0.00011385718,0.00043075663,0.00024287912,0.0000033222943,0.00012593303],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954118,0.0015913438,0.0017285006,0.00042538365,0.00071307755,0.00012992375],"domain_scores_gemma":[0.9775768,0.015325516,0.005267822,0.00018283122,0.001521613,0.00012540654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069432296,0.001062195,0.007311937,0.009399225,0.00037886304,0.0022456644,0.0012166655,0.0019140844,0.0035088744],"category_scores_gemma":[0.026303064,0.00060156325,0.0055697504,0.010417831,0.00068813504,0.0016294623,0.0008066461,0.0009595261,0.00029174113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067882653,0.000039078466,0.0022401502,0.9168536,0.010787483,0.00011620238,0.00010422973,0.0001260997,0.00030241435,0.00022199229,0.0011727964,0.067357115],"study_design_scores_gemma":[0.001014442,0.001110341,0.020732947,0.79573876,0.1535129,0.00080108346,0.00032089604,0.00024768364,0.0006915373,0.0006284298,0.025114443,0.00008662136],"about_ca_topic_score_codex":0.00407223,"about_ca_topic_score_gemma":0.008730689,"teacher_disagreement_score":0.009399225,"about_ca_system_score_codex":0.0026826144,"about_ca_system_score_gemma":0.0053873416,"threshold_uncertainty_score":0.03671974},"labels":[],"label_agreement":null},{"id":"W2969722359","doi":"10.3233/blc-190228","title":"Investigating the STING Pathway to Explain Mechanisms of BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications","year":2019,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Sting; Bladder cancer; Medicine; Cancer; Oncology; Cancer research; Internal medicine; Engineering","score_opus":0.01753233826615099,"score_gpt":0.2573248348540697,"score_spread":0.2397924965879187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969722359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530886,0.03970259,0.0041078115,0.0008655359,0.00005755227,0.000104210725,0.00027767805,0.00006849386,0.001727522],"genre_scores_gemma":[0.9915201,0.00662892,0.0010414994,0.000102557,0.00005337129,0.000034787037,0.00020757667,0.0000046194527,0.00040649617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984837,0.00004187909,0.000015838796,0.000019963121,0.000027542252,0.00004633246],"domain_scores_gemma":[0.99960595,0.00008946473,0.0001758619,0.00003538248,0.000038229944,0.000055053533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074797345,0.00041402748,0.00036900345,0.00078149675,0.00020170782,0.00055597944,0.0004044572,0.000495574,0.0017523668],"category_scores_gemma":[0.0004993603,0.00014606786,0.00038655984,0.00048079537,0.00048509132,0.00067132426,0.00026372843,0.0006422504,0.00031226999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052772732,0.0005550685,0.41130427,0.0022180835,0.00019206652,0.0045209345,0.00062603434,0.0028677294,0.46205258,0.0027550503,0.0012622733,0.10636863],"study_design_scores_gemma":[0.00015925334,0.006290275,0.6668574,0.0008390889,0.00072599924,0.021780662,0.0012754753,0.023072885,0.24862956,0.006188718,0.024113601,0.00006701597],"about_ca_topic_score_codex":0.00022674655,"about_ca_topic_score_gemma":0.00026542813,"teacher_disagreement_score":0.0017523668,"about_ca_system_score_codex":0.00047646477,"about_ca_system_score_gemma":0.00039641984,"threshold_uncertainty_score":0.0058622956},"labels":[],"label_agreement":null},{"id":"W2996535743","doi":"10.3233/blc-190252","title":"Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial","year":2019,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Ipsen; Incyte; Astellas Pharma; Clovis Oncology; Exelixis; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Docetaxel; Ramucirumab; Medicine; Internal medicine; Placebo; Hazard ratio; Subgroup analysis; Oncology; Chemotherapy; Adverse effect; Progression-free survival; Urology; Confidence interval; Pathology","score_opus":0.016504199327409465,"score_gpt":0.29406316570677776,"score_spread":0.2775589663793683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996535743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95922023,0.034646288,0.000671844,0.00042117084,0.0004549504,0.0013330394,0.0015269219,0.00005195268,0.0016736124],"genre_scores_gemma":[0.99306023,0.0035980353,0.00038880462,0.00036633236,0.0002517612,0.00075613003,0.0009129428,0.0000128201755,0.00065300765],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99793315,0.0011729934,0.00029375948,0.00026558252,0.00015786015,0.0001767087],"domain_scores_gemma":[0.9988269,0.00048388648,0.0003071071,0.00017785442,0.000065983855,0.00013825845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038334955,0.001226247,0.0037002093,0.00069020723,0.00030660882,0.0011132106,0.0005493598,0.0008658523,0.0026706578],"category_scores_gemma":[0.0029999244,0.00039005242,0.007612275,0.00061412796,0.0004537301,0.00055370963,0.0004379675,0.0014216602,0.00031144137],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9238085,0.0009936736,0.0106538385,0.0020908804,0.031480253,0.00016746954,0.00008852952,0.0007909853,0.0024884602,0.00013819132,0.001073041,0.026226291],"study_design_scores_gemma":[0.8047874,0.06967835,0.0454605,0.0004250999,0.07188899,0.00038381803,0.0001798593,0.0015349742,0.0015238237,0.0007964348,0.0032635282,0.00007720411],"about_ca_topic_score_codex":0.00062989246,"about_ca_topic_score_gemma":0.0027151804,"teacher_disagreement_score":0.0038334955,"about_ca_system_score_codex":0.00058410905,"about_ca_system_score_gemma":0.00073859957,"threshold_uncertainty_score":0.020273745},"labels":[],"label_agreement":null},{"id":"W3008603272","doi":"10.3233/blc-190254","title":"Statins are Associated with Reduced Overall and Cancer-Specific Mortality in Patients Undergoing Radical Cystectomy for Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Ministère de la Santé et des Services sociaux","keywords":"Medicine; Cystectomy; Bladder cancer; Hazard ratio; Statin; Proportional hazards model; Internal medicine; Confidence interval; Cancer; Comorbidity; Cohort; Surgery","score_opus":0.023399208467932805,"score_gpt":0.26997773912077444,"score_spread":0.24657853065284163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008603272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966066,0.0016715757,0.000071249924,0.00029420253,0.000010993886,0.000007752497,0.00087178557,0.0000051884263,0.000460588],"genre_scores_gemma":[0.9991757,0.0002829325,0.000049801485,0.00005211109,0.000008872332,0.0000027962742,0.0003232988,0.0000012008999,0.00010334777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995833,0.00008607647,0.00004884232,0.000083095634,0.000081676146,0.00011709571],"domain_scores_gemma":[0.99753165,0.00030562998,0.0014208284,0.00009312676,0.00032540504,0.00032339076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044052835,0.00013491801,0.00022895506,0.00043432403,0.00043322123,0.00050050975,0.00036677724,0.00032794022,0.0018085205],"category_scores_gemma":[0.002899082,0.00014973643,0.00044052754,0.0010262091,0.00029185772,0.00022575984,0.000374729,0.0005739316,0.00012230537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007406061,0.000008511046,0.99850684,0.000014502707,0.00003867363,0.000014160364,0.000021768796,0.000022105574,0.000050909173,0.0000067289916,0.000108066495,0.0011336255],"study_design_scores_gemma":[0.000004092322,0.00001579389,0.9995584,0.00001048944,0.000029744166,0.0000305862,0.000050046187,0.00012570168,0.000014204872,0.000010430684,0.00014866411,0.0000017950725],"about_ca_topic_score_codex":0.2554642,"about_ca_topic_score_gemma":0.39412054,"teacher_disagreement_score":0.2554642,"about_ca_system_score_codex":0.0015468413,"about_ca_system_score_gemma":0.002278177,"threshold_uncertainty_score":0.5079545},"labels":[],"label_agreement":null},{"id":"W3008920943","doi":"10.3233/blc-190262","title":"Does 5-alpha Reductase Inhibitor Use Improve The Efficacy of Intravesical Bacille Calmette-Guérin (BCG) for Non-muscle Invasive Bladder Cancer?","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Bladder cancer; Medicine; Concomitant; Proportional hazards model; Internal medicine; Urology; Cancer; Univariate analysis; Multivariate analysis; Oncology","score_opus":0.03247378600753348,"score_gpt":0.3002018281045135,"score_spread":0.26772804209698003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008920943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98394173,0.014464157,0.00012295142,0.00061820284,0.00004540274,0.000019428338,0.00011498265,0.000010438616,0.0006626766],"genre_scores_gemma":[0.9972144,0.0022023004,0.0001356382,0.00016132601,0.0000906503,0.0000061830956,0.00009654221,0.000001815957,0.00009112441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934787,0.00025802918,0.00009899039,0.00007948005,0.00013506404,0.00008046987],"domain_scores_gemma":[0.99739814,0.00081459887,0.0014012192,0.00007559591,0.000108291504,0.000202115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013408266,0.000091453956,0.0006816559,0.00026536587,0.000119429,0.00034272202,0.0003284856,0.0003690483,0.00084174756],"category_scores_gemma":[0.0043016705,0.00007569724,0.0006448587,0.00033890994,0.00019358899,0.00030645102,0.00014070468,0.000358991,0.00012888809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008987948,0.001297834,0.83602315,0.0006152633,0.0013546627,0.00017840549,0.0001100872,0.00038289776,0.0023098376,0.00008599017,0.0005317008,0.14812219],"study_design_scores_gemma":[0.0003254752,0.010896483,0.9844013,0.00014171739,0.0009941753,0.00040285912,0.00007032051,0.0005775211,0.0009027538,0.000036333924,0.0012433622,0.000007834371],"about_ca_topic_score_codex":0.0011016164,"about_ca_topic_score_gemma":0.002763594,"teacher_disagreement_score":0.0013408266,"about_ca_system_score_codex":0.00034365593,"about_ca_system_score_gemma":0.00049561367,"threshold_uncertainty_score":0.0070910454},"labels":[],"label_agreement":null},{"id":"W3036728523","doi":"10.3233/blc-200291","title":"Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; University of Manitoba; Juravinski Cancer Centre; London Health Sciences Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Saint John Regional Hospital; Queen Elizabeth II Health Sciences Centre; University of Alberta; McGill University Health Centre; University of Ottawa; CancerCare Manitoba; University Health Network; Ottawa Hospital; University of Calgary; Princess Margaret Cancer Centre; Dalhousie University; Western University; University of Toronto","funders":"","keywords":"Guideline; Medicine; Bladder cancer; MEDLINE; Standardization; Intensive care medicine; Genitourinary system; Multidisciplinary approach; Evidence-based medicine; Clinical trial; Medical physics; Cancer; Alternative medicine; Pathology; Internal medicine","score_opus":0.03972413607044959,"score_gpt":0.32816742248379516,"score_spread":0.28844328641334555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036728523","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00783381,0.41062683,0.022222906,0.44133824,0.013549083,0.0077664154,0.01774601,0.00069739926,0.07821918],"genre_scores_gemma":[0.07024738,0.5640275,0.21735092,0.082339,0.0026825266,0.005679932,0.027524386,0.0002778045,0.029870674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98691934,0.0027317663,0.0037787207,0.00066333316,0.004785318,0.0011216247],"domain_scores_gemma":[0.9545356,0.0031173925,0.0026772101,0.0003435127,0.0359962,0.0033300691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01256483,0.0015762863,0.002181428,0.00809993,0.003703968,0.0033857313,0.0064651924,0.0053243204,0.003172903],"category_scores_gemma":[0.02995564,0.00086655014,0.0032941285,0.009771812,0.0020317459,0.0021358014,0.003091011,0.0053381394,0.0018036161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008082877,0.00010029933,0.006713017,0.018420463,0.0003749505,0.0007593092,0.0013770637,0.001835424,0.0008002835,0.004028711,0.74160784,0.22390191],"study_design_scores_gemma":[0.00027652565,0.00009310912,0.018091863,0.07828127,0.0012577154,0.0012004066,0.0015210798,0.0015282612,0.0006552747,0.004152781,0.89272404,0.00021769757],"about_ca_topic_score_codex":0.70114565,"about_ca_topic_score_gemma":0.82481503,"teacher_disagreement_score":0.95751995,"about_ca_system_score_codex":0.042480048,"about_ca_system_score_gemma":0.1971155,"threshold_uncertainty_score":0.6012287},"labels":[],"label_agreement":null},{"id":"W3087173170","doi":"10.3233/blc-200304","title":"Review: Brain Metastases in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Oncology; Internal medicine; Bladder cancer; Chemotherapy; Cancer; Immune checkpoint; Immunotherapy","score_opus":0.05421260220501826,"score_gpt":0.35685702628000804,"score_spread":0.30264442407498976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087173170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009685578,0.99740297,0.00006282537,0.0004774361,0.0009344705,0.0000104402925,0.000044716624,0.000008045205,0.0009622393],"genre_scores_gemma":[0.0005220509,0.9975883,0.00009516012,0.0004310668,0.0008202262,0.000008177058,0.000059071666,0.0000021764674,0.0004737452],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995777,0.0000791357,0.00012543885,0.000057847683,0.00013053844,0.000029363237],"domain_scores_gemma":[0.99858105,0.0006817114,0.00029126325,0.000027174117,0.00032387825,0.00009490634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004903271,0.00097004813,0.001796309,0.0037582726,0.0004048414,0.0014646958,0.0010952302,0.0013530737,0.00724805],"category_scores_gemma":[0.0021220148,0.0003396863,0.000798249,0.0048353607,0.00053309265,0.0016044299,0.00070904876,0.0015524818,0.0025679658],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000875852,0.000047092475,0.000512955,0.082978435,0.00024085687,0.00078742224,0.00012648838,0.00031613186,0.00054981577,0.0009918856,0.20791578,0.7054455],"study_design_scores_gemma":[0.000019002886,0.00007647916,0.0024016092,0.041342314,0.00033212733,0.0054403855,0.00012236707,0.000060826518,0.0001586182,0.00089391763,0.94912297,0.000029327677],"about_ca_topic_score_codex":0.0025212876,"about_ca_topic_score_gemma":0.004356351,"teacher_disagreement_score":0.00724805,"about_ca_system_score_codex":0.000970699,"about_ca_system_score_gemma":0.002213277,"threshold_uncertainty_score":0.02424711},"labels":[],"label_agreement":null},{"id":"W3088838079","doi":"10.3233/blc-200315","title":"Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Radiation therapy; Adjuvant; Immune system; Oncology; Combination therapy; Cancer; Immune checkpoint; Adjuvant therapy; Neoadjuvant therapy; Urology; Internal medicine; Cancer research; Immunology; Breast cancer","score_opus":0.041541753087410156,"score_gpt":0.31149986409305747,"score_spread":0.2699581110056473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088838079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98809135,0.0065323696,0.0037275504,0.00014375064,0.000055515127,0.00026616582,0.00009690906,0.000071604976,0.0010147559],"genre_scores_gemma":[0.98815644,0.003017065,0.007762059,0.000073194,0.000035253965,0.00022870259,0.00010356144,0.000015229319,0.00060863013],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997893,0.000060265305,0.000020664129,0.0000421248,0.00004788356,0.00003978631],"domain_scores_gemma":[0.9998573,0.00002998862,0.000056030174,0.000011637097,0.000011193817,0.00003379279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043581,0.00034557347,0.0005693986,0.00031845464,0.000114662114,0.00029595965,0.00036209574,0.00026411997,0.001196035],"category_scores_gemma":[0.00030402606,0.00017054626,0.00024385679,0.00021381659,0.00020008499,0.00027084688,0.00021020373,0.00061351276,0.00027625245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0125879,0.0045563993,0.0037532803,0.0007667202,0.00011006183,0.000092784736,0.000078078505,0.009314732,0.8762645,0.00037590295,0.0005167739,0.09158288],"study_design_scores_gemma":[0.0030590156,0.0920618,0.0155783435,0.0001287823,0.0005209593,0.0007523293,0.00007805232,0.01173075,0.86470914,0.00043519068,0.010895087,0.000050556977],"about_ca_topic_score_codex":0.0002656256,"about_ca_topic_score_gemma":0.0008611956,"teacher_disagreement_score":0.001196035,"about_ca_system_score_codex":0.00029702813,"about_ca_system_score_gemma":0.0006971981,"threshold_uncertainty_score":0.004001081},"labels":[],"label_agreement":null},{"id":"W3108500360","doi":"10.3233/blc-200306","title":"Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Subtyping; Bladder cancer; Oncology; Medicine; Cancer; Internal medicine; Biology","score_opus":0.06357876085516496,"score_gpt":0.3230142290459608,"score_spread":0.2594354681907958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108500360","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004049057,0.9287551,0.01967904,0.039269757,0.002253278,0.00028663757,0.00073027366,0.00013315554,0.0048437053],"genre_scores_gemma":[0.1168068,0.78805757,0.06302019,0.023063317,0.004817266,0.0007949244,0.0016482773,0.00018587339,0.001605779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9853779,0.007382638,0.0029805463,0.0010755569,0.0029387758,0.0002445583],"domain_scores_gemma":[0.9367732,0.04783397,0.0059984988,0.0022304782,0.006474972,0.0006888996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022204397,0.0010247739,0.0029094673,0.009195032,0.0008167467,0.004933758,0.0021716736,0.0018242248,0.0017481502],"category_scores_gemma":[0.06312452,0.0005118574,0.002499148,0.00571827,0.0034410984,0.008159277,0.0029085653,0.003021244,0.0008198055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029598872,0.00004908393,0.007733904,0.098697476,0.0015714485,0.00054742285,0.0028263126,0.00095916126,0.0018427105,0.028017443,0.03526961,0.8221895],"study_design_scores_gemma":[0.00012509842,0.0003738951,0.01108667,0.19234034,0.003922256,0.0037054429,0.006893783,0.0014035266,0.0028256315,0.099132344,0.6779667,0.00022435018],"about_ca_topic_score_codex":0.003741896,"about_ca_topic_score_gemma":0.0047939727,"teacher_disagreement_score":0.022204397,"about_ca_system_score_codex":0.0027446551,"about_ca_system_score_gemma":0.008616081,"threshold_uncertainty_score":0.117429495},"labels":[],"label_agreement":null},{"id":"W3119352309","doi":"10.3233/blc-200404","title":"Revisiting an Old Conundrum: A Systematic Review and Meta-Analysis of Intravesical Therapy for Treatment of Urothelial Carcinoma of the Prostate","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meta-analysis; Prostate; Cochrane Library; Urology; Prostate cancer; Oncology; Systematic review; Carcinoma; Internal medicine; MEDLINE; Cancer","score_opus":0.12519937408883575,"score_gpt":0.39779407978007686,"score_spread":0.2725947056912411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119352309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014559664,0.9961475,0.0004676772,0.0010495436,0.00038232104,0.00016498606,0.0001486336,0.0000143635,0.0001690994],"genre_scores_gemma":[0.11700677,0.8710693,0.0034932818,0.005480541,0.0011759691,0.0010363482,0.00040331102,0.000061684106,0.00027278773],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9459688,0.03338908,0.013860387,0.002571348,0.0034779801,0.00073250436],"domain_scores_gemma":[0.9087868,0.06940777,0.013016054,0.0033042796,0.0048454357,0.0006397119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05668546,0.0028251142,0.021534812,0.00827024,0.0006733035,0.0057888026,0.0028174168,0.0034027663,0.002809747],"category_scores_gemma":[0.112894624,0.001726542,0.030380463,0.0078664245,0.0016909344,0.005000671,0.0020953852,0.002611963,0.0003332292],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082671246,0.000017952994,0.0020067315,0.5208356,0.45666227,0.00012478844,0.00021298027,0.00032360436,0.00025474533,0.0004237089,0.0012739616,0.017036928],"study_design_scores_gemma":[0.0006672546,0.0003213978,0.0031629778,0.15168661,0.83578676,0.00013994162,0.00021571189,0.00025470383,0.00016219166,0.0011787587,0.006376364,0.00004734731],"about_ca_topic_score_codex":0.0053841975,"about_ca_topic_score_gemma":0.014741912,"teacher_disagreement_score":0.05668546,"about_ca_system_score_codex":0.003353393,"about_ca_system_score_gemma":0.0073086596,"threshold_uncertainty_score":0.29978496},"labels":[],"label_agreement":null},{"id":"W3126958718","doi":"10.3233/blc-200391","title":"Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly –An International Multicenter Study","year":2021,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Cystectomy; Urothelial carcinoma; Adjuvant chemotherapy; Medicine; Urology; Multicenter study; Chemotherapy; Adjuvant; Oncology; Internal medicine; Bladder cancer; Cancer; Randomized controlled trial","score_opus":0.024553411180815967,"score_gpt":0.32220724958652663,"score_spread":0.2976538384057107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126958718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984517,0.0010441622,0.00003087117,0.00006241123,0.00001029712,0.00001008055,0.00017441007,0.0000015687635,0.00021433338],"genre_scores_gemma":[0.9994159,0.00020231365,0.000038084767,0.00005500848,0.000028113058,0.0000068311274,0.00022207458,9.590108e-7,0.000030745454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995153,0.00023012482,0.000050502273,0.00008868134,0.000059304253,0.000056034736],"domain_scores_gemma":[0.99767524,0.0003675611,0.0012231962,0.00012976496,0.00016509197,0.000439116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015576954,0.0002806096,0.00033170843,0.0003976945,0.00025471946,0.000518178,0.00022311472,0.00030913425,0.00059283513],"category_scores_gemma":[0.003012223,0.00010820959,0.0006174904,0.0006059483,0.0001713814,0.00024297951,0.00028007448,0.00028330044,0.00007371643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022311981,0.00010295337,0.9934953,0.000029262234,0.0003723186,0.00005935758,0.00004712807,0.0000814742,0.00026363452,0.000016162805,0.00017407988,0.0031270776],"study_design_scores_gemma":[0.00013219984,0.0007248857,0.99800926,0.000016190721,0.00030417982,0.0001500245,0.000073849755,0.00014468045,0.000065052955,0.000016341846,0.00035854304,0.0000046682667],"about_ca_topic_score_codex":0.0011326764,"about_ca_topic_score_gemma":0.0015882265,"teacher_disagreement_score":0.0015576954,"about_ca_system_score_codex":0.00028721476,"about_ca_system_score_gemma":0.00028158215,"threshold_uncertainty_score":0.008237958},"labels":[],"label_agreement":null},{"id":"W3135800657","doi":"10.3233/blc-201510","title":"A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment After Transurethral Resection","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bladder cancer; Resection; Adjuvant; Cancer; Randomized controlled trial; Urology; Oncology; Surgery; Internal medicine","score_opus":0.22093817884737793,"score_gpt":0.4348002948606458,"score_spread":0.21386211601326788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135800657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002875396,0.987921,0.0018234326,0.0013142627,0.0005968053,0.0029844802,0.001869819,0.000041589352,0.00057313417],"genre_scores_gemma":[0.07262891,0.8857682,0.013300727,0.0033733814,0.0005057258,0.021540454,0.0023374767,0.00009980102,0.0004454148],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.73816013,0.11257327,0.120549485,0.00660482,0.020723568,0.0013887848],"domain_scores_gemma":[0.5725754,0.30482596,0.08637646,0.008116715,0.027003136,0.0011023208],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.1316693,0.002822327,0.017202972,0.021457838,0.0017366947,0.005934143,0.0035848743,0.0035006646,0.003432467],"category_scores_gemma":[0.3912208,0.002313588,0.016255157,0.022638379,0.0033306568,0.0054143467,0.00349214,0.002299048,0.0004836704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020688811,0.0000076187766,0.0007357948,0.96931857,0.012641246,0.000063099775,0.00031154233,0.00008605746,0.00012800873,0.00029592906,0.00127074,0.014934543],"study_design_scores_gemma":[0.0004172895,0.00014749174,0.002888295,0.8930502,0.09099988,0.00019797691,0.0002949735,0.00012945537,0.00030730187,0.00068270357,0.010827291,0.000057121088],"about_ca_topic_score_codex":0.009339706,"about_ca_topic_score_gemma":0.02156248,"teacher_disagreement_score":0.982797,"about_ca_system_score_codex":0.011498553,"about_ca_system_score_gemma":0.028876454,"threshold_uncertainty_score":0.6963421},"labels":[],"label_agreement":null},{"id":"W3177003203","doi":"10.3233/blc-201526","title":"Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Urinary diversion; Medicine; Urinary system; Internal medicine; Cancer","score_opus":0.034779778754342836,"score_gpt":0.35125999078713294,"score_spread":0.3164802120327901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177003203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021526944,0.9968941,0.00006378332,0.00015011878,0.0000613898,0.00010867792,0.00038990166,0.0000049725572,0.0001743316],"genre_scores_gemma":[0.029673427,0.9689116,0.00031802364,0.00035721337,0.00008741489,0.00025258542,0.0002909928,0.0000045659463,0.00010418075],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99636,0.0011131761,0.0013733167,0.00033024698,0.0006813476,0.00014201457],"domain_scores_gemma":[0.9805047,0.014158132,0.0035211656,0.00021341606,0.0014057816,0.00019682533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038777867,0.0012410685,0.0066200853,0.00703253,0.00046155107,0.0018768401,0.001232162,0.0015444837,0.0035489374],"category_scores_gemma":[0.019847797,0.0008015915,0.006275068,0.00903769,0.0005904104,0.0012800504,0.00094105507,0.0006796107,0.0002300518],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002566021,0.0000145278245,0.0030533592,0.96059763,0.014974151,0.00016553057,0.00010212808,0.00006770181,0.00012560266,0.00008117194,0.0008817216,0.019679964],"study_design_scores_gemma":[0.0003404712,0.00031429782,0.019394262,0.78261614,0.18409593,0.00091688713,0.00029940341,0.00012309777,0.00023193409,0.00022639027,0.011392927,0.000048285427],"about_ca_topic_score_codex":0.006853664,"about_ca_topic_score_gemma":0.01763069,"teacher_disagreement_score":0.00703253,"about_ca_system_score_codex":0.0019204452,"about_ca_system_score_gemma":0.0056281355,"threshold_uncertainty_score":0.020507932},"labels":[],"label_agreement":null},{"id":"W3184137349","doi":"10.1007/978-3-030-70646-3_9","title":"Adjuvant Intravesical Therapy: Bacillus Calmette-Guerin","year":2021,"lang":"en","type":"book-chapter","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Epirubicin; Adjuvant; Bladder cancer; Immunotherapy; Mitomycin C; Urology; Pembrolizumab; Bladder tumor; Maintenance therapy; Oncology; Internal medicine; Surgery; Cancer; Chemotherapy; Breast cancer","score_opus":0.041737710216998215,"score_gpt":0.2944025851559552,"score_spread":0.25266487493895695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184137349","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003326343,0.48371637,0.006883773,0.0056645735,0.0045680287,0.00009590996,0.00039784293,0.00038947025,0.4949577],"genre_scores_gemma":[0.014043294,0.18801689,0.004141808,0.0045552333,0.0022169575,0.000073263494,0.0002969623,0.00010855817,0.78654706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99994767,0.000010365824,0.0000027043445,0.000010240008,0.00002257132,0.0000064797423],"domain_scores_gemma":[0.99996126,0.00001683005,0.000006960527,0.0000026015668,0.000006698887,0.0000057299603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010435803,0.0005895967,0.00036338044,0.0006495499,0.00024280327,0.00081217114,0.00042415215,0.0007347101,0.031322997],"category_scores_gemma":[0.0002299143,0.000133332,0.00021296165,0.00069433753,0.0002490197,0.000681038,0.00038565288,0.0012200082,0.012113228],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106488966,0.00024092638,0.00014755935,0.0008933124,0.000011642946,0.00035880334,0.00007652679,0.00044085295,0.0051128305,0.016162552,0.22573148,0.750717],"study_design_scores_gemma":[0.0000120648665,0.000071160684,0.00046522653,0.00030785703,0.0000094162915,0.0012944744,0.000016998358,0.00013992039,0.00078607263,0.0022908056,0.99460113,0.0000049593123],"about_ca_topic_score_codex":0.0017608184,"about_ca_topic_score_gemma":0.0055949925,"teacher_disagreement_score":0.031322997,"about_ca_system_score_codex":0.00049675256,"about_ca_system_score_gemma":0.0004766147,"threshold_uncertainty_score":0.1047858},"labels":[],"label_agreement":null},{"id":"W3186207429","doi":"10.3233/blc-211536","title":"Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations","year":2021,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; St. Joseph's Hospital; McMaster University","funders":"","keywords":"Medicine; Cirrhosis; Bladder cancer; Perioperative; Cancer; Incidence (geometry); Liver cancer; Population; Intensive care medicine; Internal medicine; Surgery; Gastroenterology","score_opus":0.0866534354349345,"score_gpt":0.3174134582990992,"score_spread":0.23076002286416472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186207429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102607955,0.9992174,0.000029058223,0.00022815121,0.00008126359,0.00000285043,0.000024904763,0.0000023505343,0.00031135514],"genre_scores_gemma":[0.00055364706,0.9990876,0.000074512296,0.00010633039,0.000081668586,0.0000029033827,0.000023403552,6.311876e-7,0.00006943588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971586,0.000056598303,0.00010349025,0.00004154879,0.000067862864,0.000014731876],"domain_scores_gemma":[0.9987754,0.0008136477,0.00019902931,0.00001567991,0.00015904983,0.00003715133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049497676,0.00055161625,0.001087476,0.0039075674,0.0003197125,0.000840629,0.00065663655,0.0006422933,0.003198323],"category_scores_gemma":[0.0022828726,0.00023855218,0.00079254934,0.004133287,0.0003517904,0.0010979652,0.00044714918,0.0009128359,0.0005915011],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008103944,0.000050310093,0.0011951342,0.10723722,0.00026330052,0.0005936993,0.00023123251,0.0002766058,0.00041064702,0.0014446328,0.034868862,0.8533473],"study_design_scores_gemma":[0.00002530077,0.00015828402,0.0064534442,0.11042234,0.0012374917,0.010095588,0.0003462124,0.0001497827,0.0002902157,0.0019834037,0.86878866,0.000049270726],"about_ca_topic_score_codex":0.0022007737,"about_ca_topic_score_gemma":0.0045903847,"teacher_disagreement_score":0.0039075674,"about_ca_system_score_codex":0.0004962878,"about_ca_system_score_gemma":0.0016032563,"threshold_uncertainty_score":0.010699451},"labels":[],"label_agreement":null},{"id":"W4220766798","doi":"10.3233/blc-211653","title":"The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"ZonMw","keywords":"Meta-analysis; Metformin; Bladder cancer; Medicine; Oncology; Incidence (geometry); Cancer; Internal medicine; Systematic review; Urology; MEDLINE; Mathematics; Chemistry; Insulin","score_opus":0.040022150992179706,"score_gpt":0.361603022945861,"score_spread":0.3215808719536813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220766798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002787587,0.9959603,0.00030536807,0.00015698565,0.00009653479,0.00017733045,0.000353692,0.000013127047,0.00014905346],"genre_scores_gemma":[0.11586864,0.8793129,0.001859869,0.0007193608,0.0002685541,0.0010322683,0.0007049726,0.000022090186,0.00021141507],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98968595,0.0051854914,0.002753731,0.000906441,0.0011270582,0.0003412858],"domain_scores_gemma":[0.9789121,0.015920207,0.0031328276,0.0005047426,0.0013088862,0.00022134447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013630814,0.0026458206,0.018274952,0.0064657405,0.0006423505,0.003077363,0.0021800147,0.0023508843,0.003337954],"category_scores_gemma":[0.036761258,0.0015715011,0.039399367,0.0071808007,0.000640007,0.0016357532,0.0016297245,0.0019500398,0.0002306637],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014885253,0.000027169333,0.0039800843,0.48159516,0.4989825,0.000107341264,0.000063256324,0.00059380505,0.00012397277,0.00013537229,0.00059444306,0.012308516],"study_design_scores_gemma":[0.00041000362,0.00016973793,0.0036439933,0.03620111,0.95760936,0.00009336544,0.00002856722,0.00020038045,0.000087333945,0.00016513969,0.0013700651,0.000020900823],"about_ca_topic_score_codex":0.0072157974,"about_ca_topic_score_gemma":0.013805443,"teacher_disagreement_score":0.018274952,"about_ca_system_score_codex":0.0029498083,"about_ca_system_score_gemma":0.00450478,"threshold_uncertainty_score":0.07208747},"labels":[],"label_agreement":null},{"id":"W4229034005","doi":"10.3233/blc-201534","title":"Systematic Review and Meta-Analysis on the Role of Perioperative Blood Transfusion in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma","year":2022,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Blood transfusion and management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cystectomy; Urothelial carcinoma; Medicine; Perioperative; Blood transfusion; Urology; Meta-analysis; General surgery; Oncology; Surgery; Internal medicine; Bladder cancer; Cancer","score_opus":0.01880628904969036,"score_gpt":0.2587386220342079,"score_spread":0.23993233298451752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229034005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003860186,0.9944469,0.0003797973,0.0002341006,0.0001642033,0.00019795426,0.00046347704,0.000017604492,0.00023574643],"genre_scores_gemma":[0.1605353,0.83372265,0.0018716111,0.0011304211,0.00038380065,0.0011155779,0.0009146268,0.000029539779,0.00029644524],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98814756,0.0058722333,0.0033300573,0.0010613397,0.001234264,0.00035449205],"domain_scores_gemma":[0.9704879,0.02286556,0.004084638,0.00068816077,0.0016183482,0.00025537921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013865395,0.0024208953,0.015909087,0.0056155534,0.0006977927,0.0030008215,0.0018490376,0.0022694417,0.0031001403],"category_scores_gemma":[0.042448036,0.0010910804,0.033776313,0.0068218317,0.00073347776,0.0015492212,0.0012674761,0.0016661953,0.00026976218],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014134003,0.00002280799,0.0050715418,0.4714998,0.5089882,0.00016683269,0.00008523873,0.0005158786,0.00020612613,0.00013224337,0.00067712186,0.011220868],"study_design_scores_gemma":[0.00032076513,0.00016075627,0.0043452797,0.0346523,0.95837027,0.000100122255,0.000035971178,0.00014262224,0.00009665897,0.0001681158,0.0015884199,0.000018817835],"about_ca_topic_score_codex":0.0065395036,"about_ca_topic_score_gemma":0.012939649,"teacher_disagreement_score":0.015909087,"about_ca_system_score_codex":0.002268765,"about_ca_system_score_gemma":0.004783044,"threshold_uncertainty_score":0.07332808},"labels":[],"label_agreement":null},{"id":"W4242249173","doi":"10.3233/blc-200013","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2020,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Blockade; Immune checkpoint; PD-L1; Cancer research; Immune system; Medicine; Immunology; Immunotherapy; Internal medicine; Receptor","score_opus":0.01940299617668309,"score_gpt":0.30818444827895886,"score_spread":0.2887814521022758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242249173","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010586738,0.9983386,0.000043858596,0.00011633906,0.00003966627,0.000082941675,0.0001536105,0.0000022382103,0.00016406142],"genre_scores_gemma":[0.024818543,0.973223,0.00052374735,0.000514426,0.0001130668,0.00043404114,0.0002436188,0.0000032984574,0.00012634174],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99543977,0.0015735594,0.001724663,0.00042439168,0.0007085104,0.00012896166],"domain_scores_gemma":[0.9777641,0.015163892,0.0052552326,0.00018025574,0.0015115833,0.00012492391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068781856,0.0010614495,0.007319244,0.009418958,0.00038125974,0.0022544812,0.0012192909,0.0019139407,0.0035154216],"category_scores_gemma":[0.02623746,0.00059937214,0.005531895,0.010443238,0.0006878856,0.0016305208,0.0008055162,0.00095381576,0.00029181765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006678987,0.000038939535,0.0022700424,0.9171583,0.010767209,0.000117145326,0.000104341154,0.00012521417,0.00030109103,0.00022008992,0.0011731264,0.067056574],"study_design_scores_gemma":[0.0010034784,0.001094747,0.020793641,0.79647815,0.15306047,0.0008037578,0.00032138222,0.00024576148,0.00068440934,0.00062156876,0.024807012,0.00008562729],"about_ca_topic_score_codex":0.0041379,"about_ca_topic_score_gemma":0.008894675,"teacher_disagreement_score":0.009418958,"about_ca_system_score_codex":0.0026978885,"about_ca_system_score_gemma":0.00544881,"threshold_uncertainty_score":0.03637576},"labels":[],"label_agreement":null},{"id":"W4242864454","doi":"10.3233/blc-219500","title":"Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer","year":2021,"lang":"en","type":"erratum","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Blockade; Immune checkpoint; PD-L1; Bladder cancer; Medicine; Cancer research; Immune system; Oncology; Cancer; Internal medicine; Immunotherapy; Immunology; Receptor","score_opus":0.014289048765207263,"score_gpt":0.31194671665820956,"score_spread":0.2976576678930023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242864454","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010586738,0.9983386,0.000043858596,0.00011633906,0.00003966627,0.000082941675,0.0001536105,0.0000022382103,0.00016406142],"genre_scores_gemma":[0.024818543,0.973223,0.00052374735,0.000514426,0.0001130668,0.00043404114,0.0002436188,0.0000032984574,0.00012634174],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543977,0.0015735594,0.001724663,0.00042439168,0.0007085104,0.00012896166],"domain_scores_gemma":[0.9777641,0.015163892,0.0052552326,0.00018025574,0.0015115833,0.00012492391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068781856,0.0010614495,0.007319244,0.009418958,0.00038125974,0.0022544812,0.0012192909,0.0019139407,0.0035154216],"category_scores_gemma":[0.02623746,0.00059937214,0.005531895,0.010443238,0.0006878856,0.0016305208,0.0008055162,0.00095381576,0.00029181765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006678987,0.000038939535,0.0022700424,0.9171583,0.010767209,0.000117145326,0.000104341154,0.00012521417,0.00030109103,0.00022008992,0.0011731264,0.067056574],"study_design_scores_gemma":[0.0010034784,0.001094747,0.020793641,0.79647815,0.15306047,0.0008037578,0.00032138222,0.00024576148,0.00068440934,0.00062156876,0.024807012,0.00008562729],"about_ca_topic_score_codex":0.0041379,"about_ca_topic_score_gemma":0.008894675,"teacher_disagreement_score":0.009418958,"about_ca_system_score_codex":0.0026978885,"about_ca_system_score_gemma":0.00544881,"threshold_uncertainty_score":0.03637576},"labels":[],"label_agreement":null},{"id":"W4323355305","doi":"10.3233/blc-220076","title":"An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Radboud Institute for Health Sciences; Radboud Universitair Medisch Centrum; Radboud Universiteit","keywords":"Bladder cancer; Germline; Cancer; Medicine; Gene; Oncology; Internal medicine; Biology; Genetics","score_opus":0.021976307643931308,"score_gpt":0.3163861492073973,"score_spread":0.294409841563466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323355305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993461,0.00017694505,0.00019505506,0.00002098962,0.000004748649,0.0000042014526,0.00017239405,0.0000031766351,0.00007643516],"genre_scores_gemma":[0.99962544,0.000030146726,0.00015764032,0.000008432082,0.0000046416785,0.0000036534757,0.000104410334,0.000001982371,0.00006368661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992843,0.00024450393,0.000060187605,0.00024476124,0.00008619413,0.00008007626],"domain_scores_gemma":[0.99731123,0.0014115812,0.00060752005,0.00023397028,0.0001715041,0.0002641494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011272711,0.00027663066,0.00034286646,0.0006015808,0.00037685534,0.00038585553,0.0003484006,0.00047952277,0.0015929115],"category_scores_gemma":[0.0036431388,0.0001941017,0.0007000787,0.0011074233,0.00029309856,0.00017082765,0.000267848,0.00054428406,0.00012814326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009025047,0.000042121537,0.99302435,0.000022403501,0.00048711002,0.00030273182,0.00007639091,0.00019955572,0.002693959,0.00003354349,0.000076809556,0.0021385686],"study_design_scores_gemma":[0.00004803011,0.00032626046,0.99742496,0.000006114123,0.0003455541,0.00046801328,0.00004196763,0.0007259873,0.0004052632,0.00005047612,0.00015187389,0.0000055191845],"about_ca_topic_score_codex":0.004867745,"about_ca_topic_score_gemma":0.00421567,"teacher_disagreement_score":0.004867745,"about_ca_system_score_codex":0.0002551881,"about_ca_system_score_gemma":0.0003944882,"threshold_uncertainty_score":0.009678781},"labels":[],"label_agreement":null},{"id":"W4381381711","doi":"10.3233/blc-230028","title":"Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Canadian Institutes of Health Research","keywords":"Bladder cancer; H3K4me3; Medicine; Epigenetics; Histone; Cancer research; Internal medicine; Immunology; Oncology; Biology; Cancer; Gene; Gene expression; Promoter; Genetics","score_opus":0.03489865339660434,"score_gpt":0.3306919629090061,"score_spread":0.29579330951240174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381381711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949,0.00022373731,0.0000723383,0.000018888832,0.000002711211,0.000004057728,0.000065042135,0.000002999297,0.00012004291],"genre_scores_gemma":[0.9997272,0.00003348896,0.0000687491,0.000011857811,0.0000049242226,0.0000037128777,0.00009709157,0.0000010100808,0.00005195783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978155,0.000044716184,0.000022762491,0.00006018391,0.000039738297,0.000051147763],"domain_scores_gemma":[0.9991386,0.00015617762,0.0003939327,0.000055456472,0.00009616347,0.00015974228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022028225,0.00013635997,0.00033640378,0.00035733767,0.00028126285,0.00031265905,0.00019973598,0.00032201625,0.0009247102],"category_scores_gemma":[0.0009984695,0.00011768555,0.00019346553,0.00037303526,0.00015203231,0.0001427364,0.00020112112,0.00042178555,0.00013108329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096546905,0.000043118573,0.98842597,0.000020304566,0.00003868022,0.00026017174,0.0001009123,0.000050312454,0.007024329,0.000012826403,0.00006655592,0.0029913872],"study_design_scores_gemma":[0.000006518636,0.00017180174,0.9984012,0.0000032205335,0.000022536518,0.000532985,0.000072555675,0.0001192714,0.00058443774,0.00000984081,0.00007275786,0.0000027897242],"about_ca_topic_score_codex":0.001189187,"about_ca_topic_score_gemma":0.0016722017,"teacher_disagreement_score":0.001189187,"about_ca_system_score_codex":0.00018712517,"about_ca_system_score_gemma":0.0001577768,"threshold_uncertainty_score":0.003093481},"labels":[],"label_agreement":null},{"id":"W4386634361","doi":"10.3233/blc-230056","title":"Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer","year":2023,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"EMD Serono; National Cancer Institute; Natera; Medac; Astellas Pharma; Eisai; Genentech; UroGen Pharma; National Institutes of Health; Incyte; Bristol-Myers Squibb; AstraZeneca; University of Texas MD Anderson Cancer Center; Pfizer; Patient-Centered Outcomes Research Institute","keywords":"Bladder cancer; Medicine; Food and drug administration; Clinical trial; Drug; Intensive care medicine; Oncology; Clinical research; Cancer; Internal medicine; Pharmacology","score_opus":0.11651621659017142,"score_gpt":0.41965319554556235,"score_spread":0.30313697895539093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386634361","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032908704,0.102796525,0.53784186,0.1459679,0.01747002,0.124650635,0.0016974456,0.0021182494,0.034548674],"genre_scores_gemma":[0.17085342,0.017829029,0.67845154,0.02519225,0.006305279,0.09817395,0.0006117385,0.0002827652,0.002300061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.30741397,0.6619331,0.01643258,0.0038465078,0.009126581,0.001247344],"domain_scores_gemma":[0.17503014,0.72807425,0.033928897,0.024896251,0.031408638,0.006661683],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5636698,0.001644541,0.0034545625,0.003573184,0.00136553,0.0079682,0.004525879,0.0068701813,0.013241856],"category_scores_gemma":[0.6496415,0.0016029159,0.0041278773,0.0023669514,0.004621327,0.0062194886,0.0060023265,0.0106668025,0.002338828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03527809,0.0017131164,0.011384254,0.030795803,0.004436887,0.00048160547,0.003440445,0.01702879,0.0022572135,0.06960538,0.045378946,0.77819943],"study_design_scores_gemma":[0.086636655,0.03220036,0.01517997,0.04927626,0.006752884,0.00095300964,0.0017837987,0.08967402,0.0055716205,0.41055107,0.30086884,0.00055143796],"about_ca_topic_score_codex":0.0007067406,"about_ca_topic_score_gemma":0.0013670543,"teacher_disagreement_score":0.5636698,"about_ca_system_score_codex":0.0047120405,"about_ca_system_score_gemma":0.021008,"threshold_uncertainty_score":0.5380728},"labels":[],"label_agreement":null},{"id":"W4392599278","doi":"10.3233/blc-230082","title":"Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Biomarker; Medicine; Prioritization; Biomarker discovery; Translational research; Cancer; Intensive care medicine; Oncology; Internal medicine; Pathology; Proteomics; Biology; Business","score_opus":0.39942668439411855,"score_gpt":0.5273932410810593,"score_spread":0.1279665566869408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392599278","genre_codex":"methods","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027009765,0.046685774,0.41025802,0.3133609,0.02140899,0.12469715,0.0034343223,0.0024927417,0.05065242],"genre_scores_gemma":[0.12770301,0.009838013,0.6476874,0.072837256,0.008510332,0.12521231,0.0019274811,0.0008914027,0.0053928103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.24845587,0.6049585,0.07360272,0.011612803,0.0520431,0.009326999],"domain_scores_gemma":[0.21870817,0.35067797,0.095961735,0.10975929,0.19684942,0.02804348],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.78046596,0.0020476514,0.0050490974,0.0051680305,0.0061026444,0.021426382,0.006500342,0.013208302,0.0072660614],"category_scores_gemma":[0.6757617,0.0034852026,0.0041117547,0.0062099053,0.008765198,0.015547916,0.012622209,0.01332814,0.008762973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007834269,0.0013035124,0.035952445,0.015891254,0.0015961571,0.0010556477,0.009456266,0.0051893746,0.013005119,0.04518014,0.18546236,0.6780736],"study_design_scores_gemma":[0.0054541687,0.007917293,0.050214745,0.019989744,0.001412012,0.0010553612,0.0036246874,0.005115715,0.021195067,0.05489018,0.82857406,0.0005569229],"about_ca_topic_score_codex":0.003162455,"about_ca_topic_score_gemma":0.0041457433,"teacher_disagreement_score":0.78046596,"about_ca_system_score_codex":0.0085128965,"about_ca_system_score_gemma":0.08385756,"threshold_uncertainty_score":0.2707246},"labels":[],"label_agreement":null},{"id":"W4396793480","doi":"10.3233/blc-230086","title":"Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Bladder Cancer Advocacy Network","keywords":"Cystectomy; Bladder cancer; Lymph node; Stage (stratigraphy); Medicine; Oncology; Center (category theory); Urology; Disease; Cancer; Internal medicine; Chemistry; Biology","score_opus":0.018474022223185543,"score_gpt":0.2928376693453191,"score_spread":0.2743636471221335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396793480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994,0.00021154329,0.00014350694,0.0000342394,0.000005310838,0.0000052199016,0.00010241795,0.0000036625931,0.00009397809],"genre_scores_gemma":[0.9997087,0.000031592033,0.00009719512,0.000007002447,0.000005900927,0.000002645544,0.00011360454,0.0000011373331,0.000032017088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952734,0.00019109147,0.000044070068,0.00010005791,0.000079075515,0.000058347847],"domain_scores_gemma":[0.99792516,0.0005689824,0.00082355435,0.00014129344,0.00019460116,0.00034637883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013821345,0.00026830652,0.00028554382,0.00048348372,0.00030000566,0.000587242,0.00046667564,0.00029189195,0.0011147222],"category_scores_gemma":[0.0027700341,0.00020066294,0.00043763238,0.00052016217,0.00023333222,0.000304787,0.0005072479,0.0004248933,0.00016417247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057830614,0.0000101190235,0.99881774,0.0000029293199,0.000025095462,0.000009037778,0.000009240287,0.00008321209,0.00007602075,0.0000027758006,0.000036974867,0.00086884724],"study_design_scores_gemma":[0.000008232885,0.00008953327,0.9983693,0.0000043586133,0.00003934907,0.00012812944,0.000038957456,0.0010813846,0.00012839671,0.000014054623,0.00009553853,0.0000028267852],"about_ca_topic_score_codex":0.0030573793,"about_ca_topic_score_gemma":0.005053689,"teacher_disagreement_score":0.0030573793,"about_ca_system_score_codex":0.00042004552,"about_ca_system_score_gemma":0.00036963628,"threshold_uncertainty_score":0.0073094964},"labels":[],"label_agreement":null},{"id":"W4406400675","doi":"10.1177/23523735241304348","title":"North American study and meta-analysis evaluating performance of Bladder EpiCheck <sup>®</sup> , a FDA cleared test, in non-muscle invasive bladder cancer recurrence","year":2024,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network","funders":"","keywords":"Medicine; Bladder cancer; Cystoscopy; Cytology; Urine cytology; Internal medicine; Meta-analysis; Urine; Urology; Prospective cohort study; Cancer; Gastroenterology; Urinary system; Pathology","score_opus":0.06489310274473702,"score_gpt":0.36296035896314255,"score_spread":0.2980672562184055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406400675","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12784679,0.8654414,0.0015550178,0.00055685174,0.00044905243,0.00018921695,0.002781235,0.00008373597,0.0010967535],"genre_scores_gemma":[0.8747104,0.11818612,0.001838472,0.0011284222,0.00041805112,0.0005081054,0.0025560511,0.000065968685,0.00058855925],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920736,0.003961482,0.0014120413,0.0015493018,0.0007161379,0.00028746098],"domain_scores_gemma":[0.98117596,0.013084196,0.0029953667,0.0011160995,0.0012967426,0.0003315564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009235743,0.0015993973,0.007491238,0.0029981595,0.0007369224,0.002155734,0.0013685978,0.0018880544,0.0023074206],"category_scores_gemma":[0.022801796,0.0009516924,0.031546183,0.004875045,0.00047981835,0.0010171981,0.000961594,0.0016434477,0.00022636983],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010379935,0.00004434532,0.06919892,0.033226572,0.87840444,0.0001865365,0.00005336848,0.00084750674,0.00040151074,0.00008866794,0.0010454977,0.0061226496],"study_design_scores_gemma":[0.00097084744,0.0003506688,0.035561796,0.0019077389,0.9593653,0.00012682861,0.000030724033,0.0005307025,0.00015793576,0.00013172878,0.0008461799,0.000019469024],"about_ca_topic_score_codex":0.006824065,"about_ca_topic_score_gemma":0.009858919,"teacher_disagreement_score":0.009235743,"about_ca_system_score_codex":0.0010976766,"about_ca_system_score_gemma":0.0012287158,"threshold_uncertainty_score":0.04884386},"labels":[],"label_agreement":null},{"id":"W4407930482","doi":"10.1177/23523735251319185","title":"Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer <sup/>","year":2025,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Clinical trial; Bladder cancer; Medicine; Prioritization; Multidisciplinary approach; Task force; Genitourinary system; Cancer; Medical physics; Intensive care medicine; Internal medicine; Management science; Engineering","score_opus":0.5750571568378412,"score_gpt":0.5616935397453389,"score_spread":0.013363617092502333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407930482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030846888,0.8164389,0.0024756866,0.059930265,0.060897525,0.0038236165,0.012607387,0.00046727413,0.043050934],"genre_scores_gemma":[0.0016992893,0.8824795,0.004101144,0.060333326,0.013777213,0.0029169712,0.008705582,0.00011245662,0.025874574],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977458,0.00062448846,0.00044515028,0.00018201525,0.00083971705,0.00016269066],"domain_scores_gemma":[0.9904599,0.003313982,0.0016985378,0.00020349347,0.0034920734,0.00083194906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008100884,0.0015625792,0.0025365346,0.0034259,0.0005339971,0.0035865423,0.0025463472,0.0028685837,0.029846087],"category_scores_gemma":[0.011118819,0.0005793331,0.0028464156,0.004533953,0.00040330697,0.00220246,0.0015989222,0.003871049,0.0123591395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020181862,0.000028962233,0.000069194764,0.04166364,0.00014977918,0.0000717732,0.00003984241,0.0001646079,0.0003923408,0.0021633187,0.801455,0.15359966],"study_design_scores_gemma":[0.00015677624,0.00010607859,0.00072220684,0.031003663,0.00039099233,0.00008579674,0.000022101645,0.000050275365,0.00014540141,0.0011688598,0.96612483,0.000022854978],"about_ca_topic_score_codex":0.0058396123,"about_ca_topic_score_gemma":0.013021636,"teacher_disagreement_score":0.029846087,"about_ca_system_score_codex":0.0033640265,"about_ca_system_score_gemma":0.009829387,"threshold_uncertainty_score":0.09984517},"labels":[],"label_agreement":null},{"id":"W4415396380","doi":"10.1177/23523735251384859","title":"Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Bladder Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bladder cancer; MEDLINE; Bladder tumor; Urinary bladder; Urinary Bladder Cancer","score_opus":0.01755985747081858,"score_gpt":0.37390173788908654,"score_spread":0.356341880418268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415396380","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006961557,0.025161782,0.0027119177,0.8410121,0.037850477,0.0003073681,0.0014275751,0.00038927514,0.084177956],"genre_scores_gemma":[0.3562098,0.06716924,0.025700556,0.385736,0.03384296,0.0022439947,0.006415864,0.0013585015,0.12132311],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9698677,0.017832829,0.0013838463,0.0012924145,0.003928141,0.005695085],"domain_scores_gemma":[0.8578434,0.013367274,0.0048578675,0.0035933377,0.020402748,0.09993532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.040152427,0.00082993595,0.0012632771,0.00280753,0.0065433243,0.009776653,0.0023535509,0.0071292515,0.043347623],"category_scores_gemma":[0.05799924,0.0006041494,0.0012841882,0.003238482,0.0019171641,0.0072224475,0.023932131,0.0115346555,0.006181722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019879863,0.00037681483,0.011683649,0.0015995284,0.00015734757,0.00017714835,0.0015770369,0.000284463,0.00031578177,0.011853404,0.8180543,0.15372178],"study_design_scores_gemma":[0.00014810335,0.0001523007,0.010230203,0.0021801728,0.00010595477,0.00018602898,0.0039350213,0.00019614781,0.00021242925,0.0087390905,0.9738679,0.000046627505],"about_ca_topic_score_codex":0.011266473,"about_ca_topic_score_gemma":0.027087376,"teacher_disagreement_score":0.043347623,"about_ca_system_score_codex":0.006236094,"about_ca_system_score_gemma":0.09442798,"threshold_uncertainty_score":0.21234888},"labels":[],"label_agreement":null},{"id":"W4415924917","doi":"10.1177/23523735251395361","title":"Urothelial carcinoma and the potential clinical application of urinary extracellular vesicles: Current Status and prospects","year":2025,"lang":"en","type":"review","venue":"Bladder Cancer","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Japanese Urological Association","keywords":"Urothelial carcinoma; Biomarker; Clinical Practice; Urinary system; Precision medicine; Personalized medicine; Carcinoma","score_opus":0.017959978658533222,"score_gpt":0.3387597059886518,"score_spread":0.3207997273301186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415924917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000724816,0.99658513,0.000298411,0.001798273,0.0001435849,0.000004051348,0.000018022696,0.000009257969,0.00041844064],"genre_scores_gemma":[0.016631218,0.9801468,0.000856952,0.0011691144,0.0008479886,0.000025832427,0.00007419272,0.00000451583,0.00024338948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994004,0.00021964054,0.000084531,0.00010221114,0.00011693836,0.00007622528],"domain_scores_gemma":[0.9967102,0.0021300418,0.00034787867,0.00007384773,0.00055638957,0.0001816213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027856575,0.00043673557,0.0012094278,0.0010870803,0.00029292706,0.0021748627,0.0006938963,0.0019079471,0.0027202195],"category_scores_gemma":[0.0028859398,0.00023833461,0.00082639226,0.0011392713,0.0011789454,0.0026905905,0.0009772456,0.0014080971,0.00063262443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004894038,0.00014238374,0.0045586247,0.013882027,0.00015178889,0.0005828685,0.0002667344,0.0007463837,0.0031634965,0.01289582,0.015710426,0.94741005],"study_design_scores_gemma":[0.000085544365,0.0010414958,0.008373344,0.01603709,0.0005967262,0.0039243205,0.0013422044,0.0019554622,0.0037386892,0.020152874,0.94262105,0.00013124841],"about_ca_topic_score_codex":0.0005463652,"about_ca_topic_score_gemma":0.0006806971,"teacher_disagreement_score":0.0027856575,"about_ca_system_score_codex":0.0006454702,"about_ca_system_score_gemma":0.0020065457,"threshold_uncertainty_score":0.014732122},"labels":[],"label_agreement":null}]}